0001325964 2026-01-01 2026-03-31 0001325964 2026-05-15 0001325964 2026-03-31 0001325964 2025-12-31 0001325964 2025-01-01 2025-03-31 0001325964 us-gaap:CommonStockMember 2025-12-31 0001325964 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001325964 us-gaap:DeferredCompensationShareBasedPaymentsMember 2025-12-31 0001325964 us-gaap:RetainedEarningsMember 2025-12-31 0001325964 us-gaap:CommonStockMember 2024-12-31 0001325964 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001325964 us-gaap:DeferredCompensationShareBasedPaymentsMember 2024-12-31 0001325964 us-gaap:RetainedEarningsMember 2024-12-31 0001325964 2024-12-31 0001325964 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001325964 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001325964 us-gaap:DeferredCompensationShareBasedPaymentsMember 2026-01-01 2026-03-31 0001325964 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001325964 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001325964 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001325964 us-gaap:DeferredCompensationShareBasedPaymentsMember 2025-01-01 2025-03-31 0001325964 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001325964 us-gaap:CommonStockMember 2026-03-31 0001325964 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001325964 us-gaap:DeferredCompensationShareBasedPaymentsMember 2026-03-31 0001325964 us-gaap:RetainedEarningsMember 2026-03-31 0001325964 us-gaap:CommonStockMember 2025-03-31 0001325964 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001325964 us-gaap:DeferredCompensationShareBasedPaymentsMember 2025-03-31 0001325964 us-gaap:RetainedEarningsMember 2025-03-31 0001325964 2025-03-31 0001325964 2021-12-31 0001325964 srt:ScenarioPreviouslyReportedMember 2024-12-31 0001325964 srt:RestatementAdjustmentMember 2024-12-31 0001325964 srt:ScenarioPreviouslyReportedMember 2025-03-31 0001325964 srt:RestatementAdjustmentMember 2025-03-31 0001325964 lwlg:InvestmentBankMember lwlg:UnderwritingAgreementMember 2025-12-01 2025-12-15 0001325964 lwlg:InstitutionalInvestorMember lwlg:PurchaseAgreementMember 2025-03-17 0001325964 lwlg:InstitutionalInvestorMember lwlg:PurchaseAgreementMember 2025-03-01 2025-03-17 0001325964 lwlg:PurchaseAgreementMember 2025-12-01 2025-12-15 0001325964 lwlg:InvestmentBankingCompanyMember lwlg:SalesAgreementMember 2022-12-08 2022-12-09 0001325964 lwlg:InvestmentBankingCompanyMember lwlg:SalesAgreementMember 2026-04-01 2026-04-20 0001325964 lwlg:InvestmentBankingCompanyMember lwlg:SalesAgreementMember 2026-05-01 2026-05-15 0001325964 lwlg:InvestmentBankingCompanyMember lwlg:SalesAgreementMember 2026-05-15 0001325964 lwlg:SalesAgreementMember 2026-01-01 2026-03-31 0001325964 2023-01-01 2023-12-31 0001325964 lwlg:SalesAgreementMember 2025-01-01 2025-03-31 0001325964 lwlg:JointDevelopmentAgreementMember 2026-01-01 2026-03-31 0001325964 us-gaap:OfficeEquipmentMember 2026-03-31 0001325964 us-gaap:OfficeEquipmentMember 2025-12-31 0001325964 us-gaap:OtherMachineryAndEquipmentMember 2026-03-31 0001325964 us-gaap:OtherMachineryAndEquipmentMember 2025-12-31 0001325964 us-gaap:FurnitureAndFixturesMember 2026-03-31 0001325964 us-gaap:FurnitureAndFixturesMember 2025-12-31 0001325964 us-gaap:LeaseholdImprovementsMember 2026-03-31 0001325964 us-gaap:LeaseholdImprovementsMember 2025-12-31 0001325964 lwlg:SoftwareMember 2026-03-31 0001325964 lwlg:SoftwareMember 2025-12-31 0001325964 2017-10-01 2017-10-30 0001325964 2017-10-30 0001325964 2022-11-01 2022-11-22 0001325964 2022-11-22 0001325964 srt:MinimumMember 2026-03-31 0001325964 srt:MaximumMember 2026-03-31 0001325964 lwlg:ResearchAndDevelopmentExpensesMember 2026-01-01 2026-03-31 0001325964 lwlg:GeneralAndAdministrativeExpensesMember 2026-01-01 2026-03-31 0001325964 lwlg:ResearchAndDevelopmentExpensesMember 2025-01-01 2025-03-31 0001325964 lwlg:GeneralAndAdministrativeExpensesMember 2025-01-01 2025-03-31 0001325964 2025-07-01 2025-07-04 0001325964 lwlg:InstitutionalInvestorMember lwlg:TwoThousandTwentyThreePurchaseAgreementMember 2023-02-28 0001325964 lwlg:InstitutionalInvestorMember lwlg:TwoThousandTwentyThreePurchaseAgreementMember 2023-02-26 2023-02-28 0001325964 lwlg:InstitutionalInvestorMember lwlg:TwoThousandTwentyThreePurchaseAgreementMember 2023-03-01 2025-03-31 0001325964 lwlg:InstitutionalInvestorMember lwlg:TwoThousandTwentyThreePurchaseAgreementMember 2025-01-01 2025-03-31 0001325964 lwlg:InstitutionalInvestorMember lwlg:TwoThousandTwentyFivePurchaseAgreementMember 2025-03-17 0001325964 lwlg:InstitutionalInvestorMember lwlg:TwoThousandTwentyFivePurchaseAgreementMember 2025-03-18 2025-04-16 0001325964 lwlg:InvestmentBankMember lwlg:SalesAgreementMember 2025-12-17 0001325964 lwlg:InvestmentBankMember lwlg:SalesAgreementMember 2025-12-02 2025-12-17 0001325964 lwlg:InvestmentBankMember lwlg:SalesAgreementMember 2025-12-18 2026-03-31 0001325964 lwlg:InvestmentBankMember 2026-01-01 2026-03-31 0001325964 lwlg:InvestmentBankMember 2026-04-01 2026-04-16 0001325964 lwlg:InvestmentBankingCompanyMember lwlg:SalesAgreementMember 2025-12-18 2026-03-31 0001325964 lwlg:SalesAgreementMember 2026-04-01 2026-04-20 0001325964 lwlg:SalesAgreementMember 2026-01-01 2026-03-31 0001325964 lwlg:SalesAgreementMember 2025-01-01 2025-03-31 0001325964 lwlg:SalesAgreementMember 2026-05-01 2026-05-15 0001325964 lwlg:TwoThousandsSevenPlanMember 2026-03-31 0001325964 lwlg:TwoThousandsSixteenPlanMember 2026-03-31 0001325964 srt:MinimumMember lwlg:TwoThousandsSixteenPlanMember 2019-05-16 0001325964 srt:MaximumMember lwlg:TwoThousandsSixteenPlanMember 2019-05-16 0001325964 srt:MinimumMember lwlg:TwoThousandsSixteenPlanMember 2023-05-25 0001325964 srt:MaximumMember lwlg:TwoThousandsSixteenPlanMember 2023-05-25 0001325964 lwlg:RestrictedStockAwardsMember lwlg:TwoThousandsSixteenPlanMember 2026-03-31 0001325964 us-gaap:RestrictedStockUnitsRSUMember lwlg:TwoThousandsSixteenPlanMember 2026-03-31 0001325964 lwlg:PerformanceUnitAwardsMember lwlg:TwoThousandsSixteenPlanMember 2026-03-31 0001325964 lwlg:TwoThousandsTwentyFivePlanMember 2026-03-31 0001325964 us-gaap:RestrictedStockUnitsRSUMember lwlg:TwoThousandsTwentyFivePlanMember 2026-03-31 0001325964 lwlg:TwoThousandsTwentyFivePlanMember 2026-01-01 2026-03-31 0001325964 srt:MinimumMember 2025-01-01 2025-03-31 0001325964 srt:MaximumMember 2025-01-01 2025-03-31 0001325964 lwlg:RestrictedStockAwardsMember 2026-03-31 0001325964 lwlg:RestrictedStockAwardsMember 2025-03-31 0001325964 us-gaap:RestrictedStockUnitsRSUMember 2026-03-31 0001325964 us-gaap:RestrictedStockUnitsRSUMember 2025-03-31 0001325964 lwlg:StockOptionsMember 2026-01-01 2026-03-31 0001325964 lwlg:StockOptionsMember 2025-01-01 2025-03-31 0001325964 lwlg:RestrictedStockAwardsMember 2026-01-01 2026-03-31 0001325964 lwlg:RestrictedStockAwardsMember 2025-01-01 2025-03-31 0001325964 us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001325964 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-03-31 0001325964 lwlg:NonQualifiedStockOptionsAndWarrantsMember 2025-12-31 0001325964 lwlg:NonQualifiedStockOptionsAndWarrantsMember 2026-01-01 2026-03-31 0001325964 lwlg:NonQualifiedStockOptionsAndWarrantsMember 2026-03-31 0001325964 lwlg:NonQualifiedStockOptionsAndWarrantsMember lwlg:ExercisePriceRangeOneMember 2026-01-01 2026-03-31 0001325964 lwlg:NonQualifiedStockOptionsAndWarrantsMember lwlg:ExercisePriceRangeOneMember 2026-03-31 0001325964 lwlg:NonQualifiedStockOptionsAndWarrantsMember lwlg:ExercisePriceRangeTwoMember 2026-01-01 2026-03-31 0001325964 lwlg:NonQualifiedStockOptionsAndWarrantsMember lwlg:ExercisePriceRangeTwoMember 2026-03-31 0001325964 lwlg:RestrictedStockAwardsMember 2025-12-31 0001325964 us-gaap:RestrictedStockUnitsRSUMember 2025-12-31 0001325964 lwlg:OptionsAndWarrantsMember 2026-01-01 2026-03-31 0001325964 lwlg:OptionsAndWarrantsMember 2025-01-01 2025-03-31 0001325964 lwlg:NonVestedRestrictedStockUnitsMember 2026-01-01 2026-03-31 0001325964 lwlg:NonVestedRestrictedStockUnitsMember 2025-01-01 2025-03-31 0001325964 us-gaap:RelatedPartyMember 2025-01-01 2025-03-31 0001325964 us-gaap:RelatedPartyMember 2025-12-31 0001325964 srt:DirectorMember 2025-01-01 2025-03-31 0001325964 srt:DirectorMember 2025-12-31 0001325964 lwlg:MembersOfBoardOfDirectorsAndAdvisoryBoardMember 2025-01-01 2025-03-31 0001325964 lwlg:MembersOfBoardOfDirectorsAndAdvisoryBoardMember 2025-12-31 0001325964 lwlg:OutsideTheUnitedStatesMember 2026-01-01 2026-03-31 0001325964 lwlg:OutsideTheUnitedStatesMember 2025-01-01 2025-03-31 0001325964 country:CH us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2026-01-01 2026-03-31 0001325964 country:CH us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2025-01-01 2025-03-31 0001325964 country:US 2026-03-31 0001325964 country:US 2025-12-31 0001325964 lwlg:OneCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-03-31 0001325964 lwlg:OneCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 iso4217:USD shares iso4217:USD shares pure utr:sqft false --12-31 2026 Q1 0001325964

10-Q true 2026-03-31 false 001-40766 Lightwave Logic, Inc. NV 82-0497368 369 Inverness Parkway Suite 350 Englewood CO 80112 720 340-4949 Common Stock, $0.001 par value per share LWLG NASDAQ Yes Yes Non-accelerated Filer true false false false 154079632

75102750

69017354

215753

190753

1183454

601101

76501957

69809208

8277725

7802183

5194882

5222252

398202

473771

1829433

1713420

2386792

2440369

4216225

4153789

85913064

79185249

779716

477939

1266857

1400008

56250

2375

6541

201821

194770

2250769

2135508

2350388

2403911

2350388

2403911

4601157

4539419

0.001

1000000

0.001

250000000

150500710

146050506

150502

146051

254934925

242016025

160192

203458

-173613328

-167312788

81311907

74645830

85913064

79185249

29167

22917

1336

2028

3490295

3089218

3262866

1837052

6754497

4928298

-6725330

-4905381

461275

187848

8029

-36409

28800

-76

-262

-6300540

-4697024

-0.04

148086169

123931841

146050506

146051

242016025

-203458

-167312788

74645830

829741 830 6543577 6544407 1750000 1750 4929178 4930928

1167936

1168

1860951

1862119

186030 186 -186

331530

516497 517 -746150 -745633

43266

-6300540

150500710

150502

254934925

-160192

-173613328

81311907

123301653

123302

180956329

-656735

-146998991

33423905

1035881 1036 1485947 1486983

5046

8024

8029

50000 50 116385 116435

225000

225

163275

163500

16942 17 20483 20500

749042

48068 48068

20000

29980

-30000

230150

-4697024

124654522

124655

183577533

-456585

-151696015

31549588

-6300540

-4697024

331530

749042

43266 230150

1342733

20500 8029

496358

454960

53577

50043

-36409

28800

25000

-26815

582353

86608

301777

41511

347951

-271457

-56250

56945

-4166

-4167

-46471

-40070

-4061179

-3490131

170944

45878

450466

853544

-621410

-899422

1862119 163500 2088366 481103 1486983 4930928 6544407 116435

10767985

1766918

6085396

-2622635

69017354

27667964

75102750

25045329

48068

28800

30000

<p id="xdx_803_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zjh6X2FFXwt4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTE 1 – NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES As used herein, “we,” “us,” “our,” and the “Company” refer to Lightwave Logic, Inc. Financial Statements The accompanying unaudited financial statements have been prepared by Lightwave Logic, Inc. These statements include all adjustments (consisting only of its normal recurring adjustments) which management believes necessary for a fair presentation of the statements and have been prepared on a consistent basis using the accounting polices described in the Summary of Significant Accounting Policies included in the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, as originally filed with the Securities and Exchange Commission on March 20, 2026 (the “2025 Annual Report”). Certain financial information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission, although the Company firmly believes that the accompanying disclosures are adequate to make the information presented not misleading. The financial statements should be read in conjunction with the financial statements and notes thereto included in the 2025 Annual Report. The interim operating results for the three months ended March 31, 2026 may not be indicative of operating results expected for the full year. History and Nature of Business Lightwave Logic, Inc. is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (“EO”) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Our Perkinamine® family of EO polymer materials is engineered for integration into silicon photonics (“SiPh”) and other photonic integrated circuit (“PIC”) platforms. When incorporated into device architectures, these materials are designed to support high-speed, high-bandwidth optical modulation with lower drive voltage requirements relative to certain conventional silicon-based approaches and certain other traditional photonic material systems, including III-V–based technologies. The electro-optic properties of these materials can allow shorter interaction lengths in modulator designs, which can contribute to more compact device footprints and increased integration density. In addition, our materials are intended to be compatible with complementary metal-oxide-semiconductor (“CMOS”) fabrication processes, which may facilitate integration into established semiconductor foundry workflows. Reduced drive voltage operation may enable lower system-level power consumption and simplified driver electronics in specific implementations. We do not manufacture optical transceivers, photonic devices, or complete optical modules. Instead, our strategy is to commercialize our technology through a combination of material sales, intellectual property licensing, process design kit (“PDK”) enablement, and royalty or other fee-based arrangements tied to customer production. Our customers and prospective customers include semiconductor foundries, silicon photonics device designers, optical module manufacturers, and system integrators serving artificial intelligence (“AI”), cloud computing, data center, and telecommunications markets. We pursue customer adoption through a structured commercialization process designed to support evaluation, integration, qualification, and production readiness within established semiconductor manufacturing ecosystems. Lightwave Logic, Inc. was organized under the laws of the State of Nevada in 1997, and it commenced with its current business plan in 2024. Fair Value of Financial Instruments The carrying values of the Company’s short-term financial instruments such as cash, accounts receivable, prepaid expenses and other assets, accounts payable and accrued expenses approximate fair values due to the short-term nature of these instruments. Revenue Recognition and Contract Liability The Company recognizes revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers. Under ASC 606, revenue is recognized when control of goods or services is transferred to a customer in an amount that reflects the consideration to which the Company expects to be entitled. To achieve this, the Company applies the five-step model: <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 20px; text-align: right">1.</td> <td style="width: 7px"> </td> <td style="text-align: justify">Identify the contract with a customer.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 20px; text-align: right">2.</td> <td style="width: 7px"> </td> <td style="text-align: justify">Identify the performance obligations in the contract.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 20px; text-align: right">3.</td> <td style="width: 7px"> </td> <td style="text-align: justify">Determine the transaction price for the contract.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 20px; text-align: right">4.</td> <td style="width: 7px"> </td> <td style="text-align: justify">Allocate the transaction price to the performance obligations.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 20px; text-align: right">5.</td> <td style="width: 7px"> </td> <td style="text-align: justify">Recognize revenue as performance obligations are satisfied.</td></tr> </table> The Company’s primary revenue streams includes technology license and material supply agreements and non-recurring engineering revenue from joint development agreements. Technology License and Material Supply Agreements The Company enters into technology license and material supply agreements, under which it grants customers a non-exclusive, royalty-bearing license to use its patented electro-optic polymer technology (the “Licensed Product”). The Company also supplies proprietary polymers to licensees for use in their manufacturing of photonic devices. The Company assesses whether the license and the supply of proprietary polymers represent distinct performance obligations. Based on this assessment, the Company has determined that the license and material supply are not distinct for financial reporting purposes because they are highly interdependent. Accordingly, the Company accounts for these as a single performance obligation. Revenue under these agreements is recognized as follows: Upfront License Fees – Nonrefundable upfront license fees are recorded as contract liability and recognized on a pro-rata basis over the contract term. Minimum Annual Royalties – Fixed royalty payments required under the contract are also recognized on a pro-rata basis over the contract term. Variable Royalties – Royalties exceeding the minimum annual amount are recognized when earned, typically when the licensee’s sales exceed the minimum threshold. Milestone Payments – Recognized only when the contractual milestone is achieved, such as when the licensee sells a specified number of units of the Licensed Product. Joint Development Agreement The Company entered into a memorandum of agreement (“MOA”) with a customer to specify certain binding terms related to the joint development of electro-optical polymer-based modulators on silicon photonics for use in communication applications. The MOA was executed in January 2026; however, the Company commenced work under the arrangement during 2025. The development work consists of preparing reference documentation and support of a multi-project wafer chip produced at a mutually agreed upon foundry, the design and post processing of fabricated chips, and complete product verification and volume manufacturing preparation, with each party to the agreement having responsibility over various deliverables for each phase. The Company evaluated the arrangement under ASC 808, Collaborative Arrangements, and concluded the arrangement meets the definition of a collaborative arrangement. The Company also concluded that certain promised services within the arrangement represent units of account with a customer and therefore are within the scope of ASC 606. Consideration received from the customer for such services is presented as net sales in the accompanying financial statements. The arrangement includes development services to be performed in phases. The Company evaluated the promised goods and services within each phase and concluded they are not separately identifiable because they are highly interdependent and represent inputs to a combined output that is delivered and accepted at the phase level. Accordingly, each phase is accounted for as a single combined performance obligation. Phases 1 and 2 are within the scope of ASC 606. Phase 1 consideration was $130,000, which the Company recognized in net sales upon completion and delivery to the customer of the Phase 1 products and services. Phase 2 consideration was $200,000, payable in installments subject to customer’s confirmation of completion and acceptance of the related deliverables. Deliverables and consideration for Phase 3 have not been determined. The Company recognizes revenue at a point in time upon completion and customer acceptance of the phase deliverables, as applicable. Customer acceptance is considered the substantive indicator that control of the completed phase deliverables has transferred. Contract Costs The Company capitalizes incremental costs to obtain contracts if they are expected to be recoverable, in accordance with ASC 340-40, Other Assets and Deferred Costs – Contracts with Customers. These capitalized costs are amortized over the expected contract term in a manner consistent with the related revenue recognition. The Company evaluated costs to fulfill the joint development arrangement under ASC 340-40 and concluded such costs do not meet the capitalization criteria because the costs are not expected to be recovered through the consideration payable under the arrangement. The Company expenses costs to fulfill the development arrangement as incurred, as the activities are not reimbursable and meet the definition of research and development under ASC 730. Contract Liability Contract liability represents amounts received in advance for performance obligations not yet satisfied, including nonrefundable upfront license fees. The Company recognizes contract liability revenue as revenue when the related performance obligations are satisfied. Cost of Sales Cost of sales consists of labor costs, material costs and manufacturing overhead costs associated with the production of materials transferred to the customer under the technology license and material supply agreement at the Company’s facility. Stock-based Payments The Company accounts for stock-based compensation under the provisions of FASB ASC 718, "Compensation - Stock Compensation," which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The fair value of restricted stock awards and units is estimated by the market price of the Company’s common stock at the date of grant. Restricted stock awards and units are being amortized to expense over the shorter of the requisite service period or the actual vesting period. Performance stock units are subject to both performance-based and service vesting requirements. The grant-date fair value of performance stock units is based on the fair value of the Company’s stock on a grant date and is recognized over the service period based on an assessment of the likelihood that the applicable performance goals will be achieved, and compensation expense is periodically adjusted based on actual and expected performance. The Company estimates the fair value of option and warrant awards on the date of grant using the Black-Scholes model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the shorter of the requisite service period or the actual vesting period, using the straight-line method. Consistent with the accounting requirement for employee share-based payment awards, nonemployee share-based payment awards within the scope of Topic 718 are measured at grant-date fair value of the equity instruments that an entity is obligated to issue when the good has been delivered or the service has been rendered and any other conditions necessary to earn the right to benefit from the instruments have been satisfied. The Company has elected to account for forfeiture of stock-based awards as they occur. Loss Per Share The Company follows FASB ASC 260, “Earnings per Share,” resulting in the presentation of basic and diluted earnings per share. Because the Company reported a net loss in 2026 and 2025, common stock equivalents, including stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and dilutive loss per share were the same. Comprehensive Loss The Company follows FASB ASC 220.10, “Reporting Comprehensive Income (Loss).” Comprehensive loss is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net loss. Since the Company has no items of other comprehensive loss, comprehensive loss is equal to net loss. Recently Issued Accounting Pronouncements Not Yet Adopted ASU 2024-03 – Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40) requires disclosure, in the notes to financial statements, of specified information about certain costs and expenses, such as the amounts of purchases of inventory, employee compensation, depreciation, intangible asset amortization, included in each relevant expense caption; disclosure of a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and disclosure of the total amounts of selling expenses. For public business entities, the amendments in this update are effective for annual periods beginning after December 15, 2026 and interim reporting periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is evaluating the impact of this ASU on its financial statement disclosures.

History and Nature of Business Lightwave Logic, Inc. is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (“EO”) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Our Perkinamine® family of EO polymer materials is engineered for integration into silicon photonics (“SiPh”) and other photonic integrated circuit (“PIC”) platforms. When incorporated into device architectures, these materials are designed to support high-speed, high-bandwidth optical modulation with lower drive voltage requirements relative to certain conventional silicon-based approaches and certain other traditional photonic material systems, including III-V–based technologies. The electro-optic properties of these materials can allow shorter interaction lengths in modulator designs, which can contribute to more compact device footprints and increased integration density. In addition, our materials are intended to be compatible with complementary metal-oxide-semiconductor (“CMOS”) fabrication processes, which may facilitate integration into established semiconductor foundry workflows. Reduced drive voltage operation may enable lower system-level power consumption and simplified driver electronics in specific implementations. We do not manufacture optical transceivers, photonic devices, or complete optical modules. Instead, our strategy is to commercialize our technology through a combination of material sales, intellectual property licensing, process design kit (“PDK”) enablement, and royalty or other fee-based arrangements tied to customer production. Our customers and prospective customers include semiconductor foundries, silicon photonics device designers, optical module manufacturers, and system integrators serving artificial intelligence (“AI”), cloud computing, data center, and telecommunications markets. We pursue customer adoption through a structured commercialization process designed to support evaluation, integration, qualification, and production readiness within established semiconductor manufacturing ecosystems. Lightwave Logic, Inc. was organized under the laws of the State of Nevada in 1997, and it commenced with its current business plan in 2024.

Fair Value of Financial Instruments The carrying values of the Company’s short-term financial instruments such as cash, accounts receivable, prepaid expenses and other assets, accounts payable and accrued expenses approximate fair values due to the short-term nature of these instruments.

Revenue Recognition and Contract Liability The Company recognizes revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers. Under ASC 606, revenue is recognized when control of goods or services is transferred to a customer in an amount that reflects the consideration to which the Company expects to be entitled. To achieve this, the Company applies the five-step model: <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 20px; text-align: right">1.</td> <td style="width: 7px"> </td> <td style="text-align: justify">Identify the contract with a customer.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 20px; text-align: right">2.</td> <td style="width: 7px"> </td> <td style="text-align: justify">Identify the performance obligations in the contract.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 20px; text-align: right">3.</td> <td style="width: 7px"> </td> <td style="text-align: justify">Determine the transaction price for the contract.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 20px; text-align: right">4.</td> <td style="width: 7px"> </td> <td style="text-align: justify">Allocate the transaction price to the performance obligations.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 20px; text-align: right">5.</td> <td style="width: 7px"> </td> <td style="text-align: justify">Recognize revenue as performance obligations are satisfied.</td></tr> </table> The Company’s primary revenue streams includes technology license and material supply agreements and non-recurring engineering revenue from joint development agreements.

Technology License and Material Supply Agreements The Company enters into technology license and material supply agreements, under which it grants customers a non-exclusive, royalty-bearing license to use its patented electro-optic polymer technology (the “Licensed Product”). The Company also supplies proprietary polymers to licensees for use in their manufacturing of photonic devices. The Company assesses whether the license and the supply of proprietary polymers represent distinct performance obligations. Based on this assessment, the Company has determined that the license and material supply are not distinct for financial reporting purposes because they are highly interdependent. Accordingly, the Company accounts for these as a single performance obligation. Revenue under these agreements is recognized as follows: Upfront License Fees – Nonrefundable upfront license fees are recorded as contract liability and recognized on a pro-rata basis over the contract term. Minimum Annual Royalties – Fixed royalty payments required under the contract are also recognized on a pro-rata basis over the contract term. Variable Royalties – Royalties exceeding the minimum annual amount are recognized when earned, typically when the licensee’s sales exceed the minimum threshold. Milestone Payments – Recognized only when the contractual milestone is achieved, such as when the licensee sells a specified number of units of the Licensed Product. Joint Development Agreement The Company entered into a memorandum of agreement (“MOA”) with a customer to specify certain binding terms related to the joint development of electro-optical polymer-based modulators on silicon photonics for use in communication applications. The MOA was executed in January 2026; however, the Company commenced work under the arrangement during 2025. The development work consists of preparing reference documentation and support of a multi-project wafer chip produced at a mutually agreed upon foundry, the design and post processing of fabricated chips, and complete product verification and volume manufacturing preparation, with each party to the agreement having responsibility over various deliverables for each phase. The Company evaluated the arrangement under ASC 808, Collaborative Arrangements, and concluded the arrangement meets the definition of a collaborative arrangement. The Company also concluded that certain promised services within the arrangement represent units of account with a customer and therefore are within the scope of ASC 606. Consideration received from the customer for such services is presented as net sales in the accompanying financial statements. The arrangement includes development services to be performed in phases. The Company evaluated the promised goods and services within each phase and concluded they are not separately identifiable because they are highly interdependent and represent inputs to a combined output that is delivered and accepted at the phase level. Accordingly, each phase is accounted for as a single combined performance obligation. Phases 1 and 2 are within the scope of ASC 606. Phase 1 consideration was $130,000, which the Company recognized in net sales upon completion and delivery to the customer of the Phase 1 products and services. Phase 2 consideration was $200,000, payable in installments subject to customer’s confirmation of completion and acceptance of the related deliverables. Deliverables and consideration for Phase 3 have not been determined. The Company recognizes revenue at a point in time upon completion and customer acceptance of the phase deliverables, as applicable. Customer acceptance is considered the substantive indicator that control of the completed phase deliverables has transferred. Contract Costs The Company capitalizes incremental costs to obtain contracts if they are expected to be recoverable, in accordance with ASC 340-40, Other Assets and Deferred Costs – Contracts with Customers. These capitalized costs are amortized over the expected contract term in a manner consistent with the related revenue recognition. The Company evaluated costs to fulfill the joint development arrangement under ASC 340-40 and concluded such costs do not meet the capitalization criteria because the costs are not expected to be recovered through the consideration payable under the arrangement. The Company expenses costs to fulfill the development arrangement as incurred, as the activities are not reimbursable and meet the definition of research and development under ASC 730. Contract Liability Contract liability represents amounts received in advance for performance obligations not yet satisfied, including nonrefundable upfront license fees. The Company recognizes contract liability revenue as revenue when the related performance obligations are satisfied.

Cost of Sales Cost of sales consists of labor costs, material costs and manufacturing overhead costs associated with the production of materials transferred to the customer under the technology license and material supply agreement at the Company’s facility.

Stock-based Payments The Company accounts for stock-based compensation under the provisions of FASB ASC 718, "Compensation - Stock Compensation," which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The fair value of restricted stock awards and units is estimated by the market price of the Company’s common stock at the date of grant. Restricted stock awards and units are being amortized to expense over the shorter of the requisite service period or the actual vesting period. Performance stock units are subject to both performance-based and service vesting requirements. The grant-date fair value of performance stock units is based on the fair value of the Company’s stock on a grant date and is recognized over the service period based on an assessment of the likelihood that the applicable performance goals will be achieved, and compensation expense is periodically adjusted based on actual and expected performance. The Company estimates the fair value of option and warrant awards on the date of grant using the Black-Scholes model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the shorter of the requisite service period or the actual vesting period, using the straight-line method. Consistent with the accounting requirement for employee share-based payment awards, nonemployee share-based payment awards within the scope of Topic 718 are measured at grant-date fair value of the equity instruments that an entity is obligated to issue when the good has been delivered or the service has been rendered and any other conditions necessary to earn the right to benefit from the instruments have been satisfied. The Company has elected to account for forfeiture of stock-based awards as they occur.

Loss Per Share The Company follows FASB ASC 260, “Earnings per Share,” resulting in the presentation of basic and diluted earnings per share. Because the Company reported a net loss in 2026 and 2025, common stock equivalents, including stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and dilutive loss per share were the same.

Comprehensive Loss The Company follows FASB ASC 220.10, “Reporting Comprehensive Income (Loss).” Comprehensive loss is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net loss. Since the Company has no items of other comprehensive loss, comprehensive loss is equal to net loss.

Recently Issued Accounting Pronouncements Not Yet Adopted ASU 2024-03 – Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40) requires disclosure, in the notes to financial statements, of specified information about certain costs and expenses, such as the amounts of purchases of inventory, employee compensation, depreciation, intangible asset amortization, included in each relevant expense caption; disclosure of a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and disclosure of the total amounts of selling expenses. For public business entities, the amendments in this update are effective for annual periods beginning after December 15, 2026 and interim reporting periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is evaluating the impact of this ASU on its financial statement disclosures. NOTE 2 - CORRECTION OF PRIOR-PERIOD ERRORS Error Identified in the Year Ended December 31, 2021 During the year ended December 31, 2021, the Company incorrectly expensed a portion of the value of the net shares issued by the Company in non-cash stock option exercises as compensation expense. The Company determined that the value of the net shares issued in non-cash option exercises was incorrectly expensed in the original filing, resulting in an overstatement of compensation expense. The correction of this error resulted in a decrease to accumulated deficit by $3,407,443 and a corresponding decrease to additional paid-in capital as of December 31, 2021. The cumulative impact of this correction has been reflected as an adjustment to opening accumulated deficit and additional paid-in capital in the Statements of Changes in Stockholders’ Equity as of December 31, 2024 (the beginning of the earliest period presented), and the March 31, 2025 ending balances presented in this filing. Restated Financial Information The following table presents the effects of the restatement on the Company’s previously reported statements of stockholders’ equity as of December 31, 2024 and as of March 31, 2025: <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zhpfroTcPeD6" style="font: 12pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CORRECTION OF PRIOR-PERIOD ERRORS (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: center">Schedule of restated financial information</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">As Previously Reported</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Adjustment</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">As Restated</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: italic 10pt Times New Roman, Times, Serif; text-indent: 20pt">As of December 31, 2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: left">Additional paid-in-capital</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">184,363,772</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">(3,407,443</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">180,956,329</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accumulated deficit</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(150,406,434</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,407,443</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(146,998,991</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CORRECTION OF PRIOR-PERIOD ERRORS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">As Previously Reported</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Adjustment</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">As Restated</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: italic 10pt Times New Roman, Times, Serif; text-indent: 20pt">As of March 31, 2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: left">Additional paid-in-capital</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">186,984,976</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">(3,407,443</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">183,577,533</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accumulated deficit</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(155,103,458</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,407,443</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(151,696,015</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> -3407443

<table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zhpfroTcPeD6" style="font: 12pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CORRECTION OF PRIOR-PERIOD ERRORS (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: center">Schedule of restated financial information</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">As Previously Reported</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Adjustment</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">As Restated</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: italic 10pt Times New Roman, Times, Serif; text-indent: 20pt">As of December 31, 2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: left">Additional paid-in-capital</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">184,363,772</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">(3,407,443</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">180,956,329</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accumulated deficit</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(150,406,434</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,407,443</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(146,998,991</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CORRECTION OF PRIOR-PERIOD ERRORS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">As Previously Reported</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">Adjustment</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">As Restated</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: italic 10pt Times New Roman, Times, Serif; text-indent: 20pt">As of March 31, 2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: left">Additional paid-in-capital</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">186,984,976</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">(3,407,443</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">183,577,533</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accumulated deficit</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(155,103,458</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,407,443</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(151,696,015</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt; padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table>

184363772

-3407443

180956329

-150406434

3407443

-146998991

186984976

-3407443

183577533

-155103458

3407443

-151696015

NOTE 3 – MANAGEMENT’S PLANS The Company’s future expenditures and capital requirements will depend on numerous factors, including: the progress of our research and development efforts; the rate at which the Company can, directly or through arrangements with original equipment manufacturers, introduce and sell its polymer materials technology; the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; market acceptance of the Company’s products and competing technological developments; and the Company’s ability to establish joint development, joint venture and licensing arrangements. The Company’s current cash position enables it to finance its operations through at least December 2027. On December 15, 2025, the Company entered into an underwriting agreement with an investment bank to sell <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20251201__20251215__srt--TitleOfIndividualAxis__custom--InvestmentBankMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_pd" title="Number of stock sale">13,416,667 shares of its common stock. The net proceeds to the Company from this offering were $<span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20251201__20251215__srt--TitleOfIndividualAxis__custom--InvestmentBankMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_pp0p" title="Proceeds from sale of stock">37,756,628, after deducting underwriting discounts and commissions and other offering expenses payable by the Company. On March 17, 2025, the Company entered into a purchase agreement with an institutional investor to sell up to $<span id="xdx_903_ecustom--AgreementToSellInvestCommonStockValueUpperLimitInstutionalInvestor_c20250317__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_pp0" title="Agreement to sell invest common stock value upper limit instutional investor">30,000,000 of common stock over a 36-month period (described in Note 10). This purchase agreement was terminated on <span id="xdx_90B_ecustom--DateOfTermination_c20250301__20250317__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_z27aP09CqTm9" title="Date of termination">December 15, 2025. As of the termination date, pursuant to the purchase agreement, the Company had received $3,646,655 under this agreement. On December 9, 2022, the Company entered into a sales agreement with an investment banking company whereby the Company may offer and sell shares of its common stock having an aggregate offering price of up to $<span id="xdx_904_ecustom--IncreaseInAmountOfSharesOfCommonStockThatMayBeSold_pp0d_c20221208__20221209__srt--TitleOfIndividualAxis__custom--InvestmentBankingCompanyMember__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_z2wUGwWEZjl8" title="Increase in the amount of shares of common stock that may be sold">35,000,000 from time to time through or to the investment banking company, as sales agent or principal (described in Note 10). On April 20, 2026, the Company entered into an amendment to the sales agreement to increase the amount of shares of common stock that may be sold under this agreement to $<span id="xdx_900_ecustom--IncreaseInAmountOfSharesOfCommonStockThatMayBeSold_pp0d_c20260401__20260420__srt--TitleOfIndividualAxis__custom--InvestmentBankingCompanyMember__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_z916WbYwDQA9" title="Increase in the amount of shares of common stock that may be sold">51,404,500. As of the date of this filing, pursuant to the sales agreement, the Company has sold $<span id="xdx_904_ecustom--SalesAgreementAmountReceived_pp0d_c20260501__20260515__srt--TitleOfIndividualAxis__custom--InvestmentBankingCompanyMember__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_z4uNn43jxhI7" title="Sales agreement amount received">51,401,115 in shares of common stock and has $<span id="xdx_90D_ecustom--AgreementToSellInvestCommonStockValueRemaingAmountAvailable_iI_pp0d_c20260515__srt--TitleOfIndividualAxis__custom--InvestmentBankingCompanyMember__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_zwCUkIuNoBwl" title="Agreement to sell invest common stock value remaining amount available">3,385 in shares remaining available to the Company per the agreement. The Company's first commercial agreement occurred in May 2023 from a material supply and license agreement that incorporates the Company's patented electro-optic polymer materials for use in manufacturing photonic devices (described in Note 4). For the three months ended March 31, 2026, the Company recognized $29,167 in revenue related to this agreement. The Company’s cash requirements are expected to increase at a rate consistent with the Company’s path to revenue as it expands its activities and operations with the objective of increasing its revenue stream from commercialization of its electro-optic polymer technology. The Company currently has no debt to service.

13416667

37756628

30000000 2025-12-15 3646655 35000000 51404500 51401115 3385

29167

NOTE 4 – REVENUE The Company's first commercial agreement occurred in May 2023, in the form of a four-year material supply and license agreement (the “License Agreement”) that incorporates the Company's patented electro-optic polymer materials for use in manufacturing of photonic devices (the “Licensed Product”). The licensee shall pay the Company a running royalty with a minimum royalty paid on an annual basis over the term of the License Agreement, and, if applicable, royalties that exceed the minimum royalty payments and milestone license fees. The License Agreement is a non-exclusive material supply and license agreement. In December 2025, Company entered into a memorandum of agreement (also referred to as “joint development agreement”) under which it, along with other parties, performs its respective part of the development work to develop an electro-optical polymer-based modulator chip for use in communication applications. The development work consists of preparing reference documentation and support of a multi-project wafer chip produced at a mutually agreed upon foundry, the design and post processing of fabricated chips, and complete product verification and volume manufacturing preparation, with each party to the agreement having responsibility over various deliverables for each phase. Timing of Revenue Recognition and Contract Balances Revenues related to the initial license fee and a minimum annual royalty are recognized over time commencing with the License Agreement in May 2023. An up-front license fee in the amount of $50,000 was paid during the period ended December 31, 2023. $2,375 and $6,541 of this amount is recorded as a contract liability in current liabilities on the Company’s balance sheets as of March 31, 2026 and December 31, 2025, respectively. For the three months ended March 31, 2026 and 2025, the Company recognized $29,167 and $22,917, respectively, in revenue related to this agreement. Revenues related to the joint development agreement are recognized at a point of time, when control over the performance obligations is transferred to a customer. For the three months ended March 31, 2026, the Company did not recognize any non-recurring engineering revenue related to this agreement. Contract balances are as follows: <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_z9fPjdmB9hA2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of contract balances </td><td> </td> <td colspan="2" id="xdx_49D_20260331_zv1Qr2ZfQV86"> </td><td> </td><td> </td> <td colspan="2" id="xdx_499_20251231_zHb9o5OI3iuj"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--AccountsReceivableNet_iI_pp0p" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Accounts receivable, net</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">215,753</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">190,753</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ContractWithCustomerAssetNetCurrent_iI_pp0p" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Short-term contract assets</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ContractWithCustomerAssetNetNoncurrent_iI_pp0p" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Long-term contract assets</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pp0p" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Short-term contract liability</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,375</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6,541</td><td style="text-align: left"> </td></tr> </table> Significant changes in the contract balances for the three months ended March 31, 2026 are as follows: <table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--SignificantChangesInTheContractBalancesTableTextBlock_zdvfjr8k0P89" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE (Details 1)"> <tr style="vertical-align: bottom"> <td>Schedule of significant changes in the contract balances </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Assets</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Liabilities</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%">Balance at December 31, 2025</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">190,753</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(6,541</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Revenue recognized that was previously included in contract liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,166</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Decreases/increases due to cash received</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Billed receivables recorded</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">130,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Transferred to receivables from unbilled receivables</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(130,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Unbilled receivables recorded</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">25,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Balance at March 31, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">215,753</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,375</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> Assets Recognized for the Costs to Obtain a Contract There are no assets recognized for the costs to obtain the License Agreement.

50000

2375

6541

29167

22917

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_z9fPjdmB9hA2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of contract balances </td><td> </td> <td colspan="2" id="xdx_49D_20260331_zv1Qr2ZfQV86"> </td><td> </td><td> </td> <td colspan="2" id="xdx_499_20251231_zHb9o5OI3iuj"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_407_eus-gaap--AccountsReceivableNet_iI_pp0p" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Accounts receivable, net</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">215,753</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">190,753</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ContractWithCustomerAssetNetCurrent_iI_pp0p" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Short-term contract assets</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ContractWithCustomerAssetNetNoncurrent_iI_pp0p" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Long-term contract assets</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pp0p" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Short-term contract liability</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,375</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6,541</td><td style="text-align: left"> </td></tr> </table>

215753

190753

2375

6541

<table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--SignificantChangesInTheContractBalancesTableTextBlock_zdvfjr8k0P89" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE (Details 1)"> <tr style="vertical-align: bottom"> <td>Schedule of significant changes in the contract balances </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Assets</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Liabilities</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%">Balance at December 31, 2025</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">190,753</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(6,541</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Revenue recognized that was previously included in contract liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,166</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Decreases/increases due to cash received</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Billed receivables recorded</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">130,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Transferred to receivables from unbilled receivables</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(130,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Unbilled receivables recorded</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">25,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Balance at March 31, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">215,753</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,375</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table>

190753

6541

4166

130000 -130000 25000

215753

2375

NOTE 5 – PREPAID EXPENSES AND OTHER CURRENT ASSETS Prepaid expenses and other current assets consist of the following: <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_z0mtGZTG6wUj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of prepaid expenses and other current assets </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20260331_zXXOyXUKhSrj" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20251231_zgiOFLLsko55" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_408_ecustom--WaferFabricationDeposits_iI_pp0d_maPEAOAzVpX_zR3xf7XYYdpi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Wafer fabrication deposits</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">418,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--DepositsForEquipmentPurchases_iI_pp0d_maPEAOAzVpX_ziqtMTydGlre" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deposits for equipment purchases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">234,664</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">172,937</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--PrepaidSoftwarelicenses_iI_pp0d_maPEAOAzVpX_zvKLlrfCls26" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Software licenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">232,672</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75,257</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PrepaidInsurance_iI_pp0d_maPEAOAzVpX_zq9xG7FDEUH6" style="vertical-align: bottom; background-color: White"> <td>Insurance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">112,426</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">194,258</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--InvestorRelations_iI_pp0d_maPEAOAzVpX_zLL7yMXyqcAe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Investor relations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">77,744</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,127</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--Subscriptions_iI_pp0d_maPEAOAzVpX_zLcPF1ElQ0De" style="vertical-align: bottom; background-color: White"> <td>Subscriptions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,204</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">39,934</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PrepaidRent_iI_pp0d_maPEAOAzVpX_zq1oCmZcPdze" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Rent</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">36,525</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">89,468</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OtherPrepaidExpenseCurrent_iI_pp0d_maPEAOAzVpX_z5qxNaJZD5I9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">15,719</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">23,120</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0d_mtPEAOAzVpX_zJGryqwhefd3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: rgb(204,238,255); padding-bottom: 2.5pt"> Prepaid expenses and other current assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,183,454</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">601,101</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_z0mtGZTG6wUj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of prepaid expenses and other current assets </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20260331_zXXOyXUKhSrj" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20251231_zgiOFLLsko55" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_408_ecustom--WaferFabricationDeposits_iI_pp0d_maPEAOAzVpX_zR3xf7XYYdpi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Wafer fabrication deposits</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">418,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--DepositsForEquipmentPurchases_iI_pp0d_maPEAOAzVpX_ziqtMTydGlre" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deposits for equipment purchases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">234,664</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">172,937</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--PrepaidSoftwarelicenses_iI_pp0d_maPEAOAzVpX_zvKLlrfCls26" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Software licenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">232,672</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75,257</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PrepaidInsurance_iI_pp0d_maPEAOAzVpX_zq9xG7FDEUH6" style="vertical-align: bottom; background-color: White"> <td>Insurance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">112,426</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">194,258</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--InvestorRelations_iI_pp0d_maPEAOAzVpX_zLL7yMXyqcAe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Investor relations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">77,744</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,127</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--Subscriptions_iI_pp0d_maPEAOAzVpX_zLcPF1ElQ0De" style="vertical-align: bottom; background-color: White"> <td>Subscriptions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,204</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">39,934</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PrepaidRent_iI_pp0d_maPEAOAzVpX_zq1oCmZcPdze" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Rent</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">36,525</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">89,468</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OtherPrepaidExpenseCurrent_iI_pp0d_maPEAOAzVpX_z5qxNaJZD5I9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">15,719</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">23,120</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0d_mtPEAOAzVpX_zJGryqwhefd3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: rgb(204,238,255); padding-bottom: 2.5pt"> Prepaid expenses and other current assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,183,454</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">601,101</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

418500 234664 172937 232672 75257

112426

194258

77744 6127 55204 39934

36525

89468

15719

23120

1183454

601101

NOTE 6 – PROPERTY AND EQUIPMENT Property and equipment consist of the following: <table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--PropertyPlantAndEquipmentTextBlock_zzWevMgGoUPl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of property and equipment </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Office equipment</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">199,999</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">189,694</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Lab equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,551,603</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,194,071</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Furniture</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">78,096</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">66,438</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Leasehold improvements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">462,532</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">440,855</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Software</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">180,377</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">133,377</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,472,607</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,024,435</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">8,277,725</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,802,183</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,194,882</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,222,252</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Depreciation expense for the three months ended March 31, 2026 and 2025 was $477,836 and $428,452, respectively. During the three months ended March 31, 2026, the Company did not retire any property and equipment. During the three months ended March 31, 2025, the Company traded in property and equipment with a cost and accumulated depreciation of $25,140 for a gain of $28,800.

<table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--PropertyPlantAndEquipmentTextBlock_zzWevMgGoUPl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of property and equipment </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Office equipment</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">199,999</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">189,694</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Lab equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,551,603</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,194,071</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Furniture</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">78,096</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">66,438</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Leasehold improvements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">462,532</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">440,855</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Software</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">180,377</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">133,377</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,472,607</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,024,435</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">8,277,725</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,802,183</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,194,882</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,222,252</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

199999

189694

12551603

12194071

78096

66438

462532

440855

180377

133377

13472607

13024435

8277725

7802183

5194882

5222252

477836

428452

0 25140

28800

NOTE 7 – INTANGIBLE ASSETS Intangible assets represent legal fees and patent fees associated with the prosecution of patent applications. The Company has recorded amortization expense on patents granted, which are amortized over the remaining legal life. Maintenance patent fees are paid to a government patent authority to maintain a granted patent in force. Some countries require the payment of maintenance fees for pending patent applications. Maintenance fees paid after a patent is granted are expensed, as these are considered ongoing costs to “maintain a patent”. Maintenance fees paid prior to a patent grant date are capitalized to patent costs, as these are considered “patent application costs”. No amortization expense is recorded for remaining patent applications since patents on these applications have yet to be granted. Intangible assets consist of the following: <table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zKX4Wv4srRb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of intangible assets </td><td> </td> <td colspan="2" id="xdx_49E_20260331_z9VFGsMSxUVl"> </td><td> </td><td> </td> <td colspan="2" id="xdx_497_20251231_z4UtTxcYWSBf"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedPatentsGross_iI_pp0p" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%">Patents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,227,635</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,187,191</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">398,202</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">473,771</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,829,433</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,713,420</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Amortization expense for the three months ended March 31, 2026 and 2025 was $18,522 and $26,508, respectively. During the three months ended March 31, 2026, the Company retired certain expired patents with a cost of $130,500 and accumulated amortization of $94,091 for a loss of $36,409. There were no patent costs written off for the three months ended March 31, 2025

<table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zKX4Wv4srRb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of intangible assets </td><td> </td> <td colspan="2" id="xdx_49E_20260331_z9VFGsMSxUVl"> </td><td> </td><td> </td> <td colspan="2" id="xdx_497_20251231_z4UtTxcYWSBf"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedPatentsGross_iI_pp0p" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%">Patents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,227,635</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,187,191</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">398,202</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">473,771</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,829,433</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,713,420</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

2227635

2187191

398202

473771

1829433

1713420

18522

26508

130500 94091

36409

NOTE 8 – LEASES On October 30, 2017, the Company entered into a lease agreement (the “Lease”) to lease approximately 13,420 square feet of office, chemistry, clean room and research and development space located in Colorado for the Company’s principal executive offices and research and development facility. The term of the lease was sixty-one (61) months, beginning on November 1, 2017 and ending on November 30, 2022. In January 2022, the term was extended for an additional twenty-four (24) months. On November 22, 2022, the Company entered into an amendment to the Lease (“the Amended Lease”) to lease an additional approximately 9,684 square feet of adjacent office and warehouse space. The term of the Amended Lease is one hundred twenty-eight (128) months, with an effective date of June 1, 2023. Base rent through January 31, 2024 of the Amended Lease term was approximately $30,517 per month. The base rent for the next full year of the Amended Lease term is approximately $377,288, with an increase in annual base rent of approximately 3% in each subsequent year of the lease term. Commencing on June 1, 2023, monthly installments of base rent and one-twelfth of landlord’s estimate of tenant’s proportionate share of annual operating expenses shall be due on the first day of each calendar month. The Amended Lease also provides an allowance of up to $43,216 to be used solely for the cost of renovations to the additional lease premises. For purposes of calculating operating lease liability, lease term includes the initial non-cancelable term plus any term under renewal options that are reasonably assured. Any rent escalations, along with rent abatements, are included in the computation of rent expense calculated on a straight-line basis over the lease term. The interest rate implicit in lease contracts is typically not readily determinable and as such the Company uses the appropriate incremental borrowing rate based on information available at the lease commencement date in determining the present value of the lease payments. Undiscounted future minimum lease payments under the Amended Lease as of March 31, 2026, by year and in aggregate, including the extended term, are as follows: <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zQEdSlM0gyH" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - LEASES (Details)"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left; vertical-align: top">Schedule of future lease payments of operating leases </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: bottom; text-align: center">YEARS ENDING</td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">DECEMBER 31,</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">AMOUNT</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: top; text-align: left"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 35%; text-align: left"> </td><td style="vertical-align: top; width: 40%; text-align: left">Remainder of 2026</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">300,121</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left">2027</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">411,174</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left">2028</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">423,612</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left">2029</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">436,300</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left">2030</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">449,431</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left">Thereafter</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,471,840</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,492,478</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left">Less discounted interest</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(940,269</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; vertical-align: top; text-align: left"> </td><td style="padding-bottom: 2.5pt; vertical-align: top; text-align: left">TOTAL</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,552,209</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The Company has elected not to recognize right-of-use assets and lease liabilities arising from short-term leases. There are no other material operating leases. The following table presents weighted average assumptions used to compute the Company’s right-of-use assets and lease liabilities: <table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock_zm0mXBPXvwU3" style="font: 12pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASES (Details 1)"> <tr style="vertical-align: bottom"> <td>Schedule of operating lease right-of-use assets</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">March 31, 2026</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 83%; text-align: left">Weighted average remaining lease term (in years)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">7.83</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Weighted average discount rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8.25</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> </table> As of March 31, 2026, current operating leases had remaining terms between 9 months and 7.83 years, with some leases having options to extend the lease terms. Current lease agreements do not contain any residual value guarantees or material restrictive covenants. As of March 31, 2026, the Company did not have any finance leases. Operating and short-term lease costs totaling $87,587 and $27,340 are included in research and development and general and administrative expense, respectively, for the three months ended March 31, 2026. Operating and short-term lease costs totaling $86,408 and $20,956 are included in research and development and general and administrative expenses, respectively, for the three months ended March 31, 2025.

13420

P61M

2017-11-01

2022-11-30

P24M

9684

P128M

2023-06-01

30517 377288 0.03 43216

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zQEdSlM0gyH" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - LEASES (Details)"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left; vertical-align: top">Schedule of future lease payments of operating leases </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: bottom; text-align: center">YEARS ENDING</td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">DECEMBER 31,</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">AMOUNT</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: top; text-align: left"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 35%; text-align: left"> </td><td style="vertical-align: top; width: 40%; text-align: left">Remainder of 2026</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">300,121</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left">2027</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">411,174</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left">2028</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">423,612</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left">2029</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">436,300</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left">2030</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">449,431</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left">Thereafter</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,471,840</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,492,478</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left">Less discounted interest</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(940,269</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left"> </td><td style="vertical-align: top; text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; vertical-align: top; text-align: left"> </td><td style="padding-bottom: 2.5pt; vertical-align: top; text-align: left">TOTAL</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,552,209</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

300121

411174

423612

436300

449431

1471840

3492478

940269

2552209

<table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock_zm0mXBPXvwU3" style="font: 12pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASES (Details 1)"> <tr style="vertical-align: bottom"> <td>Schedule of operating lease right-of-use assets</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">March 31, 2026</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 83%; text-align: left">Weighted average remaining lease term (in years)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">7.83</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Weighted average discount rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8.25</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> </table>

P7Y9M29D

0.0825

P9M

P7Y9M29D

87587

27340

86408

20956

NOTE 9 – INCOME TAXES There is no income tax benefit for the losses for the three months ended March 31, 2026 and 2025 since management has determined that the realization of the net deferred tax asset is not assured and has created a valuation allowance for the entire amount of such benefits. The Company’s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the statement of operations. As of January 1, 2026, the Company had no unrecognized tax benefits, or any tax related interest or penalties, and it does not expect significant changes in the amount of unrecognized tax benefits to occur within the next twelve months. There were no changes in the Company’s unrecognized tax benefits during the three-month period ended March 31, 2026. The Company did not recognize any interest or penalties during 2026 related to unrecognized tax benefits. With few exceptions, the U.S. and state income tax returns filed for the tax years ended on December 31, 2022 and thereafter are subject to examination by the relevant taxing authorities. Net operating loss (NOL) carryforwards are subject to examination in the year they are utilized regardless of whether the tax year in which they are generated has been closed by the statute. The amount subject to disallowance is limited to the NOL utilized. Accordingly, the Company may be subject to examination for prior NOLs generated as such NOLs are utilized. On July 4, 2025, the U.S. H.R.1, an act to provide for reconciliation pursuant to title II of H. Con. Res. 14. (the “OBBBA”) was enacted. The OBBBA introduces multiple tax law and other legislative changes, including modifications to income tax provisions such as existing 21% corporate income tax rate made permanent, domestic research and development expenses, the restoration of 100% bonus depreciation, changes to Section 163(j) interest limitations, and U.S. taxation of international earnings; the repeal or acceleration of the sunset of certain tax credits under the 2022 Inflation Reduction Act and elimination of certain penalties for violations of certain regulatory credit programs. The Company recognized the effects of the OBBBA provisions in its financial results to the extent they are applicable to the year ended December 31, 2025 and will continue to evaluate the impact of these provisions on its 2026 and subsequent financial statements.

0.21

NOTE 10 – STOCKHOLDERS’ EQUITY Preferred Stock Pursuant to the Company’s Articles of Incorporation, the Company’s Board of Directors is empowered, without stockholder approval, to issue series of preferred stock with any designations, rights and preferences as they may from time to time determine. The rights and preferences of this preferred stock may be superior to the rights and preferences of the Company’s common stock; consequently, preferred stock, if issued could have dividend, liquidation, conversion, voting or other rights that could adversely affect the voting power or other rights of the common stock. Additionally, preferred stock, if issued, could be utilized, under special circumstances, as a method of discouraging, delaying or preventing a change in control of the Company’s business or a takeover from a third party. Common Stock On July 26, 2024, the Company filed a $100,000,000 universal shelf registration statement with the U.S. Securities and Exchange Commission which became effective on August 5, 2024. On February 28, 2023, the Company entered into a purchase agreement with an institutional investor to sell up to $<span id="xdx_904_ecustom--AgreementToSellInvestCommonStockValueUpperLimitInstutionalInvestor_c20230228__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyThreePurchaseAgreementMember_pp0" title="Agreement to sell invest common stock value upper limit institutional investor">30,000,000 of common stock over a 36-month period. Concurrently with entering into the purchase agreement, the Company also entered into a registration rights agreement which provides the institutional investor with certain registration rights related to the shares issued under the purchase agreement. Pursuant to the purchase agreement, the Company issued <span id="xdx_90C_ecustom--AdditionalSharesIssued_c20230226__20230228__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyThreePurchaseAgreementMember_pd" title="Additional shares issued">50,891 shares of common stock to the institutional investor as an initial commitment fee valued at $<span id="xdx_90B_ecustom--AdditionalSharesIssuedAmount_c20230226__20230228__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyThreePurchaseAgreementMember_pp0p" title="Additional shares issued amount">279,391 fair value, and <span id="xdx_903_ecustom--SharesReservedForAdditionalCommitmentFeesToInstitutionalInvestor_c20230226__20230228__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyThreePurchaseAgreementMember_pd" title="Common stock reserved for additional commitment fees to the institutional investor">101,781 shares of common stock were reserved for additional commitment fees to the institutional investor in accordance with the terms of the purchase agreement. During the period February 28, 2023 through March 31, 2025, the institutional investor purchased <span id="xdx_907_ecustom--StockIssuedUnder2023PurchaseAgreementDuringPeriod_c20230301__20250331__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyThreePurchaseAgreementMember_pd" title="Stock issued under the 2023 purchase agreement during the period">7,756,336 shares of common stock for proceeds of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230301__20250331__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyThreePurchaseAgreementMember_pp0p" title="Proceeds from common stock">30,000,000 and the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230301__20250331__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyThreePurchaseAgreementMember_pd" title="Common stock issued for commitment shares, shares">101,781 shares of common stock as additional commitment fee, valued at $<span id="xdx_903_ecustom--AdditionalSharesIssuedAmount_c20230301__20250331__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyThreePurchaseAgreementMember_pp0p" title="Additional shares issued amount">518,265 fair value, leaving zero in reserve for additional commitment fees. During the three months ended March 31, 2025, pursuant to the purchase agreement, the institutional investor purchased <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250101__20250331__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyThreePurchaseAgreementMember_pd" title="Common stock shares sold">1,035,881 shares of common stock for proceeds of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20250101__20250331__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyThreePurchaseAgreementMember_pp0p" title="Proceeds from common stock">1,486,983 and the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250101__20250331__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyThreePurchaseAgreementMember_pd" title="Common stock issued for commitment shares, shares">5,046 shares of common stock as additional commitment fee, valued at $<span id="xdx_903_ecustom--AdditionalSharesIssuedAmount_c20250101__20250331__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyThreePurchaseAgreementMember_pp0p" title="Additional shares issued amount">8,029 fair value. On March 17, 2025, the Company entered into a new purchase agreement with the same institutional investor to sell up to $<span id="xdx_906_ecustom--AgreementToSellInvestCommonStockValueUpperLimitInstutionalInvestor_c20250317__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyFivePurchaseAgreementMember_pp0" title="Agreement to sell invest common stock value upper limit institutional investor">30,000,000 of common stock over a 36-month period. Concurrently with entering into the purchase agreement, the Company also entered into a registration rights agreement which provides the institutional investor with certain registration rights related to the shares issued under the purchase agreement. Pursuant to the purchase agreement, the Company issued <span id="xdx_90F_ecustom--AdditionalSharesIssued_c20250318__20250416__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyFivePurchaseAgreementMember_pd" title="Additional shares issued">245,098 shares of common stock to the institutional investor as an initial commitment fee valued at $<span id="xdx_90D_ecustom--AdditionalSharesIssuedAmount_c20250318__20250416__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyFivePurchaseAgreementMember_pp0p" title="Additional shares issued amount">222,990 fair value, and <span id="xdx_90D_ecustom--SharesReservedForAdditionalCommitmentFeesToInstitutionalInvestor_c20250318__20250416__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--AwardTypeAxis__custom--TwoThousandTwentyFivePurchaseAgreementMember_pd" title="Common stock reserved for additional commitment fees to the institutional investor">490,196 shares of common stock were reserved for additional commitment fees to the institutional investor in accordance with the terms of the purchase agreement. During the three months ended March 31, 2025, the institutional investor did not purchase any shares of common stock under this agreement. This purchase agreement was terminated on December 15, 2025 in conjunction with an offering to sell shares of the Company’s common stock to an investment bank. On December 17, 2025, the Company closed the offering with an investment bank to sell up to <span id="xdx_90E_ecustom--AgreementToSellInvestCommonStockValueUpperLimitInvestmentBank_c20251217__srt--TitleOfIndividualAxis__custom--InvestmentBankMember__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_pp0" title="Agreement to sell invest common stock value upper limit investment bank">13,416,667 shares of its common stock, including up to <span id="xdx_904_ecustom--AdditionalSharesIssued_c20251202__20251217__srt--TitleOfIndividualAxis__custom--InvestmentBankMember__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_zieJp8sizwxi" title="Additional shares issued">1,750,000 shares to cover over-allotments. Pursuant to the underwriting agreement for the offering, the Company agreed to issue to the underwriter warrants to purchase up to <span id="xdx_902_ecustom--UnderwriterWarrantsPurchased_c20251202__20251217__srt--TitleOfIndividualAxis__custom--InvestmentBankMember__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_zextweOsEBh2" title="Underwriter warrants purchase">350,000 shares of common stock, or three percent (<span id="xdx_906_ecustom--CommonStockSoldInOfferingRate_c20251202__20251217__srt--TitleOfIndividualAxis__custom--InvestmentBankMember__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_zi96lRCgMJM8" title="Common stock sold in offering rate">3%) of the total number of shares of common stock sold in the offering, as well as additional underwriter warrants to purchase up to an aggregate of <span id="xdx_906_ecustom--AdditionalUnderwriterWarrantsPurchased_c20251202__20251217__srt--TitleOfIndividualAxis__custom--InvestmentBankMember__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_zA7hHLDRI8v3" title="Additional underwriter warrants purchased">52,500 shares of common stock in connection with the exercise of the over-allotment option by the underwriter. During the period from December 17, 2025 through March 31, 2026, the Company sold <span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20251218__20260331__srt--TitleOfIndividualAxis__custom--InvestmentBankMember__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_zrFUgixQ4Ts1" title="Common stock shares sold">13,416,667 shares under this agreement for the net proceeds of $<span id="xdx_903_ecustom--IncreaseInAmountOfSharesOfCommonStockThatMayBeSold_pp0d_c20251218__20260331__srt--TitleOfIndividualAxis__custom--InvestmentBankMember__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_zmtR6OKNpWTg" title="Increase in the amount of shares of common stock that may be sold">37,756,628, after deducting underwriting discounts and commissions and other offering expenses payable by the Company. The underwriter warrants were immediately exercisable at an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20251217__srt--TitleOfIndividualAxis__custom--InvestmentBankMember__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_pd" title="Exercise price">3.45 per share during the five-year <span id="xdx_908_eus-gaap--DebtInstrumentTerm_dtY_c20251202__20251217__srt--TitleOfIndividualAxis__custom--InvestmentBankMember__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_zwiBWlF9RUu5" style="display: none" title="Debt instrument, term">5 period following the date of the underwriting agreement. As of March 31, 2026, 402,500 underwriter warrants were outstanding and no underwriting warrants were exercised during the three months period ended March 31, 2026. On April 16, 2026, all 402,500 underwriter warrants were exercised for proceeds of $1,388,625. On December 9, 2022, the Company entered into a sales agreement with an investment banking company. In accordance with the terms of this sales agreement, the Company may offer and sell shares of its common stock having an aggregate offering price of up to $<span id="xdx_900_ecustom--IncreaseInAmountOfSharesOfCommonStockThatMayBeSold_c20251218__20260331__srt--TitleOfIndividualAxis__custom--InvestmentBankingCompanyMember__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_z5JDUpN0OG5" title="Increase in the amount of shares of common stock that may be sold">35,000,000 from time to time through or to the investment banking company, as sales agent or principal. Sales of shares of the Company’s common stock, if any, may be made by any method deemed to be an “at-the-market offering”. The sales agent is entitled to compensation under the terms of the sales agreement at a commission rate equal to <span id="xdx_908_ecustom--AgreementCommisionRate_c20221208__20221209__srt--TitleOfIndividualAxis__custom--InvestmentBankingCompanyMember__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_zh5YYlDq3Yjf" title="Commission rate">3% of the gross proceeds of the sales price of common stock that they sell. On April 20, 2026, the Company entered into an amendment to the sales agreement to increase the amount of shares of common stock that may be sold under this agreement to $<span id="xdx_903_ecustom--AmountIncreasedForSaleOfCommonStock_pp0d_c20260401__20260420__us-gaap--TransactionTypeAxis__custom--SalesAgreementMember_zX4btrxPyrp4" title="Amount increased for sale of common stock">51,404,500. During the three months period ended March 31, 2026, pursuant to the sales agreement, the investment banking company sold 829,741 shares of the Company’s common stock for proceeds of $6,544,407 after a payment of the commission in the amount of $203,602 to the investment banking company and underwriting expenses of $38,722. During the three months period ended March 31, 2025, pursuant to the sales agreement, the investment banking company sold 50,000 shares of the Company’s common stock for proceeds of $116,435 after a payment of the commission in the amount of $3,602 to the investment banking company. During the period from April 1, 2026 through May 15, 2026, pursuant to the sales agreement, the investment banking company sold 1,794,185 shares of the Company’s common stock for proceeds of $21,357,710 after a payment of the commission in the amount of $491,451 to the investment banking company.

30000000 50891 279391 101781 7756336

30000000

101781

518265

1035881

1486983

5046

8029 30000000 245098 222990 490196 13416667 1750000 350000 0.03 52500

13416667

37756628

3.45

P5Y

402500 0 402500

1388625

35000000 0.03 51404500

829741

6544407

203602 38722

50000

116435

3602

1794185

21357710

491451

NOTE 11 – STOCK BASED COMPENSATION Common Stock Options and Warrants During 2007, the Board of Directors of the Company adopted the 2007 Employee Stock Plan (“2007 Plan”) that was approved by the shareholders. Under the 2007 Plan, the Company is authorized to grant options to purchase up to <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c20260331__us-gaap--PlanNameAxis__custom--TwoThousandsSevenPlanMember_pd" title="Number of shares authorized under plan">10,000,000 shares of common stock to directors, officers, employees and consultants who provide services to the Company. The 2007 Plan is intended to permit stock options granted to employees under the 2007 Plan to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended (“Incentive Stock Options”). All options granted under the 2007 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be non-qualified options (“Non-Statutory Stock Options”). Effective June 24, 2016, the 2007 Plan was terminated. As of March 31, 2026, there are <span id="xdx_90C_ecustom--NumberOfCommonSharesAvailableToBePurchasedThroughOptionsIssuedAndOutstanding_iI_do_c20260331__us-gaap--PlanNameAxis__custom--TwoThousandsSevenPlanMember_z26u140sJV53" title="Number of common shares available to be purchased through options issued and outstanding">no options to purchase shares of common stock outstanding under the 2007 Plan. During 2016, the Board of Directors of the Company adopted the 2016 Equity Incentive Plan (“2016 Plan”) that was approved by the shareholders at the 2016 annual meeting of shareholders on May 20, 2016. Under the 2016 Plan, the Company is authorized to grant awards of incentive and non-qualified stock options and restricted stock to purchase up to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c20260331__us-gaap--PlanNameAxis__custom--TwoThousandsSixteenPlanMember_pd" title="Number of shares authorized under plan">3,000,000 shares of common stock to employees, directors and consultants. Effective May 16, 2019, the number of shares of the Company’s common stock available for issuance under the 2016 Plan was increased from <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c20190516__us-gaap--PlanNameAxis__custom--TwoThousandsSixteenPlanMember__srt--RangeAxis__srt--MinimumMember_pd" title="Number of shares authorized under plan">3,000,000 to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c20190516__us-gaap--PlanNameAxis__custom--TwoThousandsSixteenPlanMember__srt--RangeAxis__srt--MaximumMember_pd" title="Number of shares authorized under plan">8,000,000 shares. Effective May 25, 2023, the number of shares of the Company’s common stock available for issuance under the 2016 Plan was increased from <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c20230525__us-gaap--PlanNameAxis__custom--TwoThousandsSixteenPlanMember__srt--RangeAxis__srt--MinimumMember_pd" title="Number of shares authorized under plan">8,000,000 to <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c20230525__us-gaap--PlanNameAxis__custom--TwoThousandsSixteenPlanMember__srt--RangeAxis__srt--MaximumMember_pd" title="Number of shares authorized under plan">13,000,000 shares and awards of restricted stock units were authorized for issuance. Effective May 15, 2025, the 2016 Plan was terminated. As of March 31, 2026, options to purchase <span id="xdx_903_ecustom--NumberOfCommonSharesAvailableToBePurchasedThroughOptionsIssuedAndOutstanding_c20260331__us-gaap--PlanNameAxis__custom--TwoThousandsSixteenPlanMember_pd" title="Number of common shares available to be purchased through options issued and outstanding">6,590,023 shares of common stock have been issued and are outstanding, <span id="xdx_90A_ecustom--CommonStockGranted_c20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandsSixteenPlanMember_pd" title="Common stock granted">498,694 restricted shares of common stock have been granted, net of forfeitures, <span id="xdx_901_ecustom--CommonStockGranted_c20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandsSixteenPlanMember_pd" title="Common stock granted">1,616,380 restricted stock units have been granted, and <span id="xdx_903_ecustom--CommonStockIssued_c20260331__us-gaap--AwardTypeAxis__custom--PerformanceUnitAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandsSixteenPlanMember_pd" title="Common stock issued">542,566 performance stock units have been issued under the 2016 Plan. During 2025, the Board of Directors of the Company adopted the 2025 Equity Incentive Plan (“2025 Plan”) that was approved by the shareholders at the 2025 annual meeting of shareholders on May 15, 2025. Under the 2025 Plan, the Company is authorized to grant awards of incentive and non-qualified stock options and restricted stock to purchase up to <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c20260331__us-gaap--PlanNameAxis__custom--TwoThousandsTwentyFivePlanMember_pd" title="Number of shares authorized under plan">6,000,000 shares of common stock to employees, directors and consultants. As of March 31, 2026, options to purchase <span id="xdx_90A_ecustom--NumberOfCommonSharesAvailableToBePurchasedThroughOptionsIssuedAndOutstanding_c20260331__us-gaap--PlanNameAxis__custom--TwoThousandsTwentyFivePlanMember_pd" title="Number of common shares available to be purchased through options issued and outstanding">601,244 shares of common stock have been issued and are outstanding and <span id="xdx_902_ecustom--CommonStockGrantedNetOfForfeiture_iI_c20260331__us-gaap--PlanNameAxis__custom--TwoThousandsTwentyFivePlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zCct8Flx0Rw9" title="Common stock granted, net of forfeiture">2,621,813 restricted stock units have been granted under the 2025 Plan, net of forfeitures. As of March 31, 2026, <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20260331__us-gaap--PlanNameAxis__custom--TwoThousandsTwentyFivePlanMember_pd" title="Common stock remaining for grants">2,738,812 shares of common stock remain available for grants under the 2025 Plan. These plans are administered by the Company’s Board of Directors or its compensation committee which determines the persons to whom awards will be granted, the number of awards to be granted, and the specific terms of each grant. Options granted under the 2025 Plan are generally exercisable for a period of <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20260101__20260331__us-gaap--PlanNameAxis__custom--TwoThousandsTwentyFivePlanMember_zCGwVBHlNr52" title="Exercisable period">10 years from the date of grant and may vest on the grant date, another specified date or over a period of time. The Company uses the <span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionMethodUsed_c20260101__20260331_z6idyK7TLtK3" title="Pricing model used in calculation of grant-date fair value">Black-Scholes option pricing model to calculate the grant-date fair value of an award, with the following assumptions for the three months ended March 31, 2026: no dividend yield, expected volatility, based on the Company’s historical volatility, 83.6%, risk-free interest rate of 4.14% and expected option life of 10 years, which is based on the legal contractual life of the options. The Black-Scholes option pricing model assumptions for the three months ended March 31, 2025 are as follows: no dividend yield, expected volatility, based on the Company’s historical volatility, <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c20250101__20250331__srt--RangeAxis__srt--MinimumMember_pd" title="Expected volatility">78.7% to <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c20250101__20250331__srt--RangeAxis__srt--MaximumMember_pd" title="Expected volatility">79.0%, risk-free interest rate between <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c20250101__20250331__srt--RangeAxis__srt--MinimumMember_pd" title="Risk-free interest rate">4.18% to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c20250101__20250331__srt--RangeAxis__srt--MaximumMember_pd" title="Risk-free interest rate">4.40% and expected option life of 10 years, which is based on the legal contractual life of the options. As of March 31, 2026, there was $1,732,150 of unrecognized compensation expense related to non-vested market-based share awards that is expected to be recognized through December 2028. Share-based compensation was recognized as follows: <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_z1SRcNzw9hxd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK BASED COMPENSATION (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of share-based compensation </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Stock options</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">331,530</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">749,042</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Restricted stock awards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">43,266</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">230,150</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left">Restricted stock units</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,342,733</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"> Total share-based compensation</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,717,529</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">979,192</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The following tables summarize all stock option and warrant activity of the Company during the three months ended March 31, 2026: <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zYs0ZDdqjLB1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK BASED COMPENSATION (Details 1)"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left; font-size: 8pt; font-weight: bold; vertical-align: bottom">Schedule of stock option and warrant activity</td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; vertical-align: bottom; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; vertical-align: bottom; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"> </td><td colspan="9" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Non-Qualified Stock Options and Warrants Outstanding and Exercisable</td><td style="padding-bottom: 1pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="vertical-align: bottom; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-size: 8pt; font-weight: bold"> </td> <td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-size: 8pt; font-weight: bold"> </td> <td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-size: 8pt; font-weight: bold"> </td> <td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt; font-weight: bold"> </td> <td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt; font-weight: bold"> </td> <td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt; font-weight: bold"> </td> <td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; width: 1%; text-align: left"> </td><td style="vertical-align: bottom; width: 53%; text-align: left">Outstanding, December 31, 2025</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zPYIZOY1OLce" title="Number of shares outstanding, beginning balance">8,996,078</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"> $<span id="xdx_905_ecustom--ShareBasedCompensationSharesOutstandingUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_z8TueWMEAmp4" title="Exercise price beginning balance, minimum">0.51 - $<span id="xdx_90C_ecustom--ShareBasedCompensationSharesOutstandingUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_z9qimdC6llUa" title="Exercise price beginning balance, maximum">16.81 </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zT2rImZYZJA8" title="Weighted average exercise price beginning balance">3.47</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left">Granted</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zJS84pKbfT05" title="Number of shares, granted">252,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> $<span id="xdx_90E_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePriceRangeLowerRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zyBMggAcNG1i" title="Exercise price granted, minimum">3.24 - $<span id="xdx_903_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePriceRangeUpperRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zm9B6zZO44E" title="Exercise price granted, maximum">3.45 </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zanwgBHji0Of" title="Weighted average exercise price granted">3.28</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left">Forfeited</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zs6QJo1YoOBh" title="Number of shares, forfeited">(11,875</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> $<span id="xdx_902_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeitedInPeriodExercisePriceRangeLowerRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zLyv5S2U8A97" title="Exercise price forfeited, minimum">0.99 - $<span id="xdx_90F_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeitedInPeriodExercisePriceRangeUpperRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zWacPKDyKWjb" title="Exercise price forfeited, maximum">1.96 </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zGvGPC5aukoc" title="Weighted average exercise price, forfeited">1.15</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; vertical-align: bottom; text-align: left"> </td><td style="padding-bottom: 1pt; vertical-align: bottom; text-align: left">Exercised</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zX3LAuARXMZj" title="Number of shares, exercised">(1,367,936</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> $<span id="xdx_900_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodExercisePriceRangeLowerRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zRYGm0cMZ3H9" title="Exercise price exercised, minimum">0.60 - $<span id="xdx_903_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodExercisePriceRangeUpperRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zsBEUjJntOya" title="Exercise price exercised, maximum">5.51 </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zaJN7Jy2XMY6" title="Weighted average exercise price, exercised">1.45</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; vertical-align: bottom; text-align: left"> </td><td style="padding-bottom: 2.5pt; vertical-align: bottom; text-align: left">Outstanding, March 31, 2026</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zKZdjnZRqCld" title="Number of shares outstanding, ending balance">7,868,767</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"> $<span id="xdx_90A_ecustom--ShareBasedCompensationSharesOutstandingUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zoj4hMUok5jc" title="Exercise price ending balance, minimum">0.51 - $<span id="xdx_904_ecustom--ShareBasedCompensationSharesOutstandingUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zw1etxZHFG83" title="Exercise price ending balance, maximum">16.81 </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zmLHvAfXL6Dc" title="Weighted average exercise price, ending balance">3.82</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; vertical-align: bottom; text-align: left"> </td><td style="padding-bottom: 2.5pt; vertical-align: bottom; text-align: left">Exercisable, March 31, 2026</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zHAvUIbinozf" title="Number of shares, exercisable">7,007,097</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"> $<span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeLowerRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_z1p9EG7Zn0n5" title="Exercise price exercisable, minimum">0.51 - $<span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeUpperRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zoY7Wo6ArUDi" title="Exercise price exercisable, maximum">16.81 </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_z0IHXFl9AtOb" title="Weighted average exercise price, exercisable">3.97</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The aggregate intrinsic value of options and warrants outstanding and exercisable as of March 31, 2026 was $<span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValueOptions_c20260331_pp0p" title="Aggregate intrinsic value of options and warrants outstanding">27,556,963 and $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_c20260331_pp0p" title="Aggregate intrinsic value of options and warrants exercisable">23,740,665, respectively. The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and warrants and the closing stock price of $7.03 for the Company’s common stock on March 31, 2026. During the three months ended March 31, 2026, 1,367,936 options with the aggregate intrinsic value of $7,670,268 were exercised for proceeds of $1,862,119 and no warrants were exercised. Of this amount, 200,000 options were exercised via cashless settlement. <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zL8hwOOYOC42" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK BASED COMPENSATION (Details 2)"> <tr style="vertical-align: bottom"> <td style="text-align: center">Schedule of non-qualified stock options and warrants outstanding </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="border-bottom: Black 1pt solid; text-align: center">Non-Qualified Stock Options and Warrants Outstanding Currently Exercisable</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: center; width: 22%"> Range of Exercise Prices</td><td style="padding-bottom: 1pt; text-align: center; width: 1%"> </td> <td style="padding-bottom: 1pt; width: 1%; text-align: center"> </td><td style="border-bottom: Black 1pt solid; width: 22%; text-align: center">Number Outstanding Currently Exercisable at March 31, 2026</td><td style="padding-bottom: 1pt; width: 1%; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center; width: 1%"> </td> <td style="padding-bottom: 1pt; width: 1%; text-align: center"> </td><td style="border-bottom: Black 1pt solid; width: 22%; text-align: center">Weighted Average Remaining Contractual Life</td><td style="padding-bottom: 1pt; width: 1%; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center; width: 1%"> </td> <td style="padding-bottom: 1pt; width: 1%; text-align: center"> </td><td style="border-bottom: Black 1pt solid; width: 22%; text-align: center">Weighted Average Exercise Price of Options and Warrants Currently Exercisable</td><td style="padding-bottom: 1pt; width: 1%; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> $<span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableExercisePriceRangeLowerRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zW2YSbbSM8Bc" title="Exercise prices, minimum">0.51 - $<span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableExercisePriceRangeUpperRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zwOOnuVxCrDh" title="Exercise prices, maximum">16.81</td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"><span id="xdx_90A_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingAndExercisableOptions_iI_c20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zwWAoWtALPt3" title="Number outstanding currently exercisable">7,007,097</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zXqc4fsqHfna" title="Weighted average remaining contractual life">5.6 Years</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"></td><td style="text-align: center">$<span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_pd" title="Weighted average exercise price of options and warrants currently exercisable">3.97</td><td style="text-align: center"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK BASED COMPENSATION (Details 2)"> <tr style="vertical-align: bottom"> <td colspan="12" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 5.4pt">Non-Qualified Stock Options and Warrants Outstanding</td><td style="padding-bottom: 1pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: center; width: 22%; padding-left: 5.4pt"> Range of Exercise Prices</td><td style="text-align: center; width: 1%; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; width: 1%; text-align: center"> </td><td style="border-bottom: Black 1pt solid; width: 22%; text-align: center"> Number Outstanding at March 31, 2026</td><td style="width: 1%; padding-bottom: 1pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: center">Weighted Average Remaining Contractual Life</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: center">Weighted Average Exercise Price of Options and Warrants Outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 5.4pt"> $<span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zq0hsik4Tzaf" title="Exercise prices, minimum">0.51 - $<span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zGFTDAVrg7ig" title="Exercise prices, maximum">16.81</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z9YDpxAaLk8e" title="Number of options outstanding">7,868,767</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zf1ECV6uIQP1" title="Weighted average remaining contractual life">5.7 Years</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">$<span id="xdx_90D_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePrice1_iI_c20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zQPrOoiaBPjd" title="Weighted average exercise price of options outstanding">3.82</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> Restricted Stock Awards and Units The Company grants restricted stock units (“RSUs”) and restricted stock awards (“RSAs”) to employees and directors. RSUs represent the right to receive shares of common stock upon vesting, while RSAs are shares issued at the grant date that remain subject to forfeiture until vesting conditions are met. These awards are amortized on a straight-line basis over the vesting period into stock-based compensation expense. The vesting period ranges from immediate vesting to monthly or quarterly vesting. Upon the occurrence of a Change in Control, 100% of the unvested RSAs and RSUs shall vest as of the date of the Change in Control. Upon vesting, the restrictions on the shares lapse. The fair value of restricted stock awards and units is estimated by the market price of the Company’s common stock at the date of grant. Restricted stock activity during the three months ended March 31, 2026 is as follows: <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_z5TWKsFUDZO6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK BASED COMPENSATION (Details 3)"> <tr style="vertical-align: bottom"> <td style="text-align: center">Schedule of fair value of restricted stock awards </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Restricted Stock Awards Three Month Period Ended March 31, 2026</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Restricted Stock Units Three Month Period Ended March 31, 2026</td> <td style="padding-bottom: 1pt; text-align: center"> </td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> Number of Shares</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value per Share</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> Number of Shares</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value per Share</td> <td style="padding-bottom: 1pt; text-align: center"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Non-vested, beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_zIwTXhns2Jm3" title="Number of shares non vested outstanding, beginning balance">153,596</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_zSUe8c4pHJHc" title="Weighted average fair value per share, beginning balance">1.54</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zJIGHAhPdoWk" title="Number of shares non vested outstanding, beginning balance">2,836,742</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zb7tLTxNCs48" title="Weighted average fair value per share, beginning balance">3.07</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_pd" title="Number of shares, granted">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_pd" title="Weighted average fair value per share, granted">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pd" title="Number of shares, granted">1,074,737</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pd" title="Weighted average fair value per share, granted">3.30</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Vested</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_zswHiRGLBjW1" title="Number of shares, vested">(22,462</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_pd" title="Weighted average fair value per share, vested">1.93</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zd7dF1qLhNf1" title="Number of shares, vested">(811,465</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pd" title="Weighted average fair value per share, vested">2.94</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Cancelled and forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_pd" title="Number of shares, Cancelled and forfeited">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_pd" title="Weighted average fair value per share, Cancelled and forfeited">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zrlJdsIHNuQg" title="Number of shares, Cancelled and forfeited">(14,043</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pd" title="Weighted average fair value per share, Cancelled and forfeited">3.24</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Non-vested, end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_zwefa9XLRic5" title="Number of shares non vested outstanding, ending balance">131,134</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_zpbjRen2JYl2" title="Weighted average fair value per share, ending balance">1.47</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zlwguOogZEhe" title="Number of shares non vested outstanding, ending balance">3,085,971</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zXbFHe5v7qrk" title="Weighted average fair value per share, ending balance">3.18</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Restricted stock awards and units are being amortized to expense over the shorter of the requisite service period or the vesting period. As of March 31, 2026 and 2025, the unamortized value of the RSAs was $<span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_pp0p" title="Unamortized value">160,192 and $<span id="xdx_902_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c20250331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_pp0p" title="Unamortized value">384,927, respectively. As of March 31, 2026 and 2025, the unamortized value of the RSUs was $<span id="xdx_90D_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p" title="Unamortized value">7,999,929 and $<span id="xdx_90C_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c20250331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p" title="Unamortized value">0, respectively.

10000000

3000000

8000000

13000000

6590023 498694 1616380 542566

6000000

601244 2621813

2738812

P10Y

Black-Scholes

0.836

0.0414

P10Y

Black-Scholes

0.787

0.790

0.0418

0.0440

P10Y

1732150

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_z1SRcNzw9hxd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK BASED COMPENSATION (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of share-based compensation </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Stock options</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">331,530</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">749,042</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Restricted stock awards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">43,266</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">230,150</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left">Restricted stock units</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,342,733</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"> Total share-based compensation</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,717,529</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">979,192</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

331530

749042

43266

230150

1342733

1717529

979192

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zYs0ZDdqjLB1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK BASED COMPENSATION (Details 1)"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left; font-size: 8pt; font-weight: bold; vertical-align: bottom">Schedule of stock option and warrant activity</td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 8pt; font-weight: bold"> </td><td style="font-size: 8pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; vertical-align: bottom; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; vertical-align: bottom; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-size: 8pt; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center"> </td><td colspan="9" style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Non-Qualified Stock Options and Warrants Outstanding and Exercisable</td><td style="padding-bottom: 1pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="vertical-align: bottom; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-size: 8pt; font-weight: bold"> </td> <td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-size: 8pt; font-weight: bold"> </td> <td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-size: 8pt; font-weight: bold"> </td> <td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="font-size: 8pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="vertical-align: bottom; padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt; font-weight: bold"> </td> <td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt; font-weight: bold"> </td> <td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center; font-size: 8pt; font-weight: bold"> </td> <td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt; font-size: 8pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; width: 1%; text-align: left"> </td><td style="vertical-align: bottom; width: 53%; text-align: left">Outstanding, December 31, 2025</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zPYIZOY1OLce" title="Number of shares outstanding, beginning balance">8,996,078</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"> $<span id="xdx_905_ecustom--ShareBasedCompensationSharesOutstandingUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_z8TueWMEAmp4" title="Exercise price beginning balance, minimum">0.51 - $<span id="xdx_90C_ecustom--ShareBasedCompensationSharesOutstandingUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_z9qimdC6llUa" title="Exercise price beginning balance, maximum">16.81 </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zT2rImZYZJA8" title="Weighted average exercise price beginning balance">3.47</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left">Granted</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zJS84pKbfT05" title="Number of shares, granted">252,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> $<span id="xdx_90E_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePriceRangeLowerRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zyBMggAcNG1i" title="Exercise price granted, minimum">3.24 - $<span id="xdx_903_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePriceRangeUpperRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zm9B6zZO44E" title="Exercise price granted, maximum">3.45 </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zanwgBHji0Of" title="Weighted average exercise price granted">3.28</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left">Forfeited</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zs6QJo1YoOBh" title="Number of shares, forfeited">(11,875</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> $<span id="xdx_902_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeitedInPeriodExercisePriceRangeLowerRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zLyv5S2U8A97" title="Exercise price forfeited, minimum">0.99 - $<span id="xdx_90F_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeitedInPeriodExercisePriceRangeUpperRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zWacPKDyKWjb" title="Exercise price forfeited, maximum">1.96 </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zGvGPC5aukoc" title="Weighted average exercise price, forfeited">1.15</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; vertical-align: bottom; text-align: left"> </td><td style="padding-bottom: 1pt; vertical-align: bottom; text-align: left">Exercised</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zX3LAuARXMZj" title="Number of shares, exercised">(1,367,936</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> $<span id="xdx_900_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodExercisePriceRangeLowerRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zRYGm0cMZ3H9" title="Exercise price exercised, minimum">0.60 - $<span id="xdx_903_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodExercisePriceRangeUpperRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zsBEUjJntOya" title="Exercise price exercised, maximum">5.51 </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zaJN7Jy2XMY6" title="Weighted average exercise price, exercised">1.45</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; vertical-align: bottom; text-align: left"> </td><td style="padding-bottom: 2.5pt; vertical-align: bottom; text-align: left">Outstanding, March 31, 2026</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zKZdjnZRqCld" title="Number of shares outstanding, ending balance">7,868,767</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"> $<span id="xdx_90A_ecustom--ShareBasedCompensationSharesOutstandingUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zoj4hMUok5jc" title="Exercise price ending balance, minimum">0.51 - $<span id="xdx_904_ecustom--ShareBasedCompensationSharesOutstandingUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zw1etxZHFG83" title="Exercise price ending balance, maximum">16.81 </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zmLHvAfXL6Dc" title="Weighted average exercise price, ending balance">3.82</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left"> </td><td style="vertical-align: bottom; text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; vertical-align: bottom; text-align: left"> </td><td style="padding-bottom: 2.5pt; vertical-align: bottom; text-align: left">Exercisable, March 31, 2026</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zHAvUIbinozf" title="Number of shares, exercisable">7,007,097</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"> $<span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeLowerRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_z1p9EG7Zn0n5" title="Exercise price exercisable, minimum">0.51 - $<span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeUpperRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_zoY7Wo6ArUDi" title="Exercise price exercisable, maximum">16.81 </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember_z0IHXFl9AtOb" title="Weighted average exercise price, exercisable">3.97</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

8996078

0.51 16.81

3.47

252500

3.24 3.45

3.28

11875

0.99 1.96

1.15

1367936

0.60 5.51

1.45

7868767

0.51 16.81

3.82

7007097

0.51 16.81

3.97

27556963

23740665

7.03

1367936 7670268

1862119

200000

<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zL8hwOOYOC42" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK BASED COMPENSATION (Details 2)"> <tr style="vertical-align: bottom"> <td style="text-align: center">Schedule of non-qualified stock options and warrants outstanding </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="13" style="border-bottom: Black 1pt solid; text-align: center">Non-Qualified Stock Options and Warrants Outstanding Currently Exercisable</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: center; width: 22%"> Range of Exercise Prices</td><td style="padding-bottom: 1pt; text-align: center; width: 1%"> </td> <td style="padding-bottom: 1pt; width: 1%; text-align: center"> </td><td style="border-bottom: Black 1pt solid; width: 22%; text-align: center">Number Outstanding Currently Exercisable at March 31, 2026</td><td style="padding-bottom: 1pt; width: 1%; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center; width: 1%"> </td> <td style="padding-bottom: 1pt; width: 1%; text-align: center"> </td><td style="border-bottom: Black 1pt solid; width: 22%; text-align: center">Weighted Average Remaining Contractual Life</td><td style="padding-bottom: 1pt; width: 1%; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center; width: 1%"> </td> <td style="padding-bottom: 1pt; width: 1%; text-align: center"> </td><td style="border-bottom: Black 1pt solid; width: 22%; text-align: center">Weighted Average Exercise Price of Options and Warrants Currently Exercisable</td><td style="padding-bottom: 1pt; width: 1%; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> $<span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableExercisePriceRangeLowerRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zW2YSbbSM8Bc" title="Exercise prices, minimum">0.51 - $<span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableExercisePriceRangeUpperRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zwOOnuVxCrDh" title="Exercise prices, maximum">16.81</td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"><span id="xdx_90A_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingAndExercisableOptions_iI_c20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zwWAoWtALPt3" title="Number outstanding currently exercisable">7,007,097</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zXqc4fsqHfna" title="Weighted average remaining contractual life">5.6 Years</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"></td><td style="text-align: center">$<span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_pd" title="Weighted average exercise price of options and warrants currently exercisable">3.97</td><td style="text-align: center"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK BASED COMPENSATION (Details 2)"> <tr style="vertical-align: bottom"> <td colspan="12" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 5.4pt">Non-Qualified Stock Options and Warrants Outstanding</td><td style="padding-bottom: 1pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: center; width: 22%; padding-left: 5.4pt"> Range of Exercise Prices</td><td style="text-align: center; width: 1%; padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; width: 1%; text-align: center"> </td><td style="border-bottom: Black 1pt solid; width: 22%; text-align: center"> Number Outstanding at March 31, 2026</td><td style="width: 1%; padding-bottom: 1pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: center">Weighted Average Remaining Contractual Life</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%; padding-bottom: 1pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: center"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: center">Weighted Average Exercise Price of Options and Warrants Outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 5.4pt"> $<span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zq0hsik4Tzaf" title="Exercise prices, minimum">0.51 - $<span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zGFTDAVrg7ig" title="Exercise prices, maximum">16.81</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z9YDpxAaLk8e" title="Number of options outstanding">7,868,767</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zf1ECV6uIQP1" title="Weighted average remaining contractual life">5.7 Years</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">$<span id="xdx_90D_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePrice1_iI_c20260331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsAndWarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zQPrOoiaBPjd" title="Weighted average exercise price of options outstanding">3.82</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table>

0.51 16.81 7007097

P5Y7M6D

3.97

0.51 16.81

7868767

P5Y8M12D

3.82

<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_z5TWKsFUDZO6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK BASED COMPENSATION (Details 3)"> <tr style="vertical-align: bottom"> <td style="text-align: center">Schedule of fair value of restricted stock awards </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Restricted Stock Awards Three Month Period Ended March 31, 2026</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Restricted Stock Units Three Month Period Ended March 31, 2026</td> <td style="padding-bottom: 1pt; text-align: center"> </td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> Number of Shares</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value per Share</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> Number of Shares</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant Date Fair Value per Share</td> <td style="padding-bottom: 1pt; text-align: center"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Non-vested, beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_zIwTXhns2Jm3" title="Number of shares non vested outstanding, beginning balance">153,596</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_zSUe8c4pHJHc" title="Weighted average fair value per share, beginning balance">1.54</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zJIGHAhPdoWk" title="Number of shares non vested outstanding, beginning balance">2,836,742</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zb7tLTxNCs48" title="Weighted average fair value per share, beginning balance">3.07</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_pd" title="Number of shares, granted">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_pd" title="Weighted average fair value per share, granted">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pd" title="Number of shares, granted">1,074,737</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pd" title="Weighted average fair value per share, granted">3.30</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Vested</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_zswHiRGLBjW1" title="Number of shares, vested">(22,462</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_pd" title="Weighted average fair value per share, vested">1.93</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zd7dF1qLhNf1" title="Number of shares, vested">(811,465</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pd" title="Weighted average fair value per share, vested">2.94</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Cancelled and forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_pd" title="Number of shares, Cancelled and forfeited">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_pd" title="Weighted average fair value per share, Cancelled and forfeited">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zrlJdsIHNuQg" title="Number of shares, Cancelled and forfeited">(14,043</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pd" title="Weighted average fair value per share, Cancelled and forfeited">3.24</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Non-vested, end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_zwefa9XLRic5" title="Number of shares non vested outstanding, ending balance">131,134</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20260101__20260331__us-gaap--AwardTypeAxis__custom--RestrictedStockAwardsMember_zpbjRen2JYl2" title="Weighted average fair value per share, ending balance">1.47</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zlwguOogZEhe" title="Number of shares non vested outstanding, ending balance">3,085,971</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zXbFHe5v7qrk" title="Weighted average fair value per share, ending balance">3.18</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

153596

1.54

2836742

3.07

1074737

3.30

22462

1.93

811465

2.94

14043

3.24

131134

1.47

3085971

3.18

160192

384927

7999929

NOTE 12 – LOSS PER SHARE The Company calculates earnings (loss) per share ("EPS") in accordance with FASB ASC 260, Earnings Per Share. Basic EPS is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For the three months ended March 31, 2026 and 2025, the Company reported a net loss; therefore, diluted EPS is calculated the same as basic EPS, as the inclusion of all potentially dilutive securities would be anti-dilutive. The following securities were excluded from the calculation of diluted loss per share because their effect would have been anti-dilutive: <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">·</td> <td style="text-align: justify">Options and warrants: <span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AwardTypeAxis__custom--OptionsAndWarrantsMember_pd" title="Antidilutive shares">2,687,699 shares (2026), <span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AwardTypeAxis__custom--OptionsAndWarrantsMember_pd" title="Antidilutive shares">1,869,604 shares (2025)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">·</td> <td style="text-align: justify">Unvested RSUs: <span id="xdx_90C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AwardTypeAxis__custom--NonVestedRestrictedStockUnitsMember_pd" title="Antidilutive shares">1,401,844 shares (2026), <span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AwardTypeAxis__custom--NonVestedRestrictedStockUnitsMember_pd" title="Antidilutive shares">0 shares (2025). </td></tr> </table>

2687699

1869604

1401844

NOTE 13 – RELATED PARTIES During the three months period ended March 31, 2025, the Company engaged in transactions with related parties, including consultants, directors, and entities affiliated with members of the Board of Directors. These transactions primarily relate to legal services, consulting fees, director compensation, accounting services, and expense reimbursements. Related party transactions for the months ended March 31, 2025 and as of December 31, 2025 were as follows: <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 20.3pt"></td><td style="width: 18pt">·</td><td style="text-align: justify">The Company incurred $67,543 in legal fees and expense reimbursements with a related party law firm during the three months ended March 31, 2025. Related accrual was $0 as of December 31, 2025.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 20.3pt"></td><td style="width: 18pt">·</td><td style="text-align: justify">The Company incurred $<span id="xdx_900_ecustom--AccountingAndItServiceFeesAndExpenseReimbursements_c20250101__20250331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_pp0p" title="Accounting and IT service fees and expense reimbursements">22,760 in accounting and IT service fees and expense reimbursements to related parties during the three months ended March 31, 2025. Related accrual was $0 as of December 31, 2025.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 20.3pt"></td><td style="width: 18pt">·</td><td style="text-align: justify">The Company incurred $54,795 in fees and travel expenses to directors during the three months ended March 31, 2025. Related accrual was $56,250 as of December 31, 2025.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 20.3pt"></td><td style="width: 18pt">·</td><td style="text-align: justify">The Company incurred $<span id="xdx_904_ecustom--ConsultingFeesAndTravelReimbursements_pp0d_c20250101__20250331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MembersOfBoardOfDirectorsAndAdvisoryBoardMember_zE6lKA4xbPU3" title="Consulting fees">82,500 in consulting fees to board of directors and advisory board members during the three months ended March 31, 2025. Related accrual was $<span id="xdx_908_ecustom--ConsultingAccruals_iI_pp0d_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MembersOfBoardOfDirectorsAndAdvisoryBoardMember_zPDUjFSTZ23i" title="Consulting accruals">0 as of December 31, 2025.</td></tr></table> For the three months period ended March 31, 2026, there were no material transactions with related parties.

67543

0 22760 0 54795 56250 82500 0

NOTE 14 – RETIREMENT PLAN The Company established a 401(k) retirement plan covering all eligible employees beginning November 15, 2013, which was amended effective February 15, 2025. The plan offers two types of elected deferrals: pre-tax deferrals and Roth deferrals. The Company matches 100% of each participant’s contribution, up to 4% for all eligible employees. Matching contributions vest immediately. Participants are entitled to receive distributions of all vested amounts beginning at age 59 1/2. Matching contributions to all eligible participants charged to expense were $62,328 and $39,587 for the three months ended March 31, 2026 and 2025, respectively. The plan is subject to the annual IRS elective deferral limit of $24,500 per employee for 2026, $8,000 catch-up for those aged 50 and over, and $11,250 special catch-up limit for those aged 60-63.

62328

39587

24500 $8,000 catch-up for those aged 50 and over, and $11,250 special catch-up limit for those aged 60-63.

NOTE 15 – SEGMENT REPORTING The Company operates as a single reportable segment, as the Chief Operating Decision Maker (“3”), the Chief Executive Officer (“CEO”), evaluates the business as a whole and does not receive discrete financial information for separate business units. The CODM is responsible for evaluating financial results and making resource allocation decisions. The Company determined that it has one operating and reportable segment based on the way the CODM organizes, manages, and evaluates the Company’s operations on a consolidated basis. The CODM assesses the Company's financial performance based on operating loss, which aligns with the amount reported in the statements of comprehensive loss. The following table presents a reconciliation of segment operating loss to net loss for the three months ended March 31, 2026 and 2025: <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zcRJs45A3L9i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT REPORTING (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of reconciliation of segment operating loss </td><td> </td> <td colspan="2" id="xdx_494_20260101__20260331_zlz1A8IWeZik"> </td><td> </td><td> </td> <td colspan="2" id="xdx_490_20250101__20250331_zmBgmQBHeVp6"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended March 31, 2026</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended March 31, 2025</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> </tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_401_eus-gaap--Revenues_i_pp0p" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left; padding-bottom: 1pt">NET SALES</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">29,167</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">22,917</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--CostOfGoodsAndServicesSold_i_pp0p" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>COST OF SALES</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,336</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,028</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingExpensesAbstract_iB_z4hTWDOF0WF" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">OPERATING EXPENSES</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--ResearchAndDevelopmentExpense_i_pp0p" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 12px">Research and development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,490,295</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,089,218</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--GeneralAndAdministrativeExpense_i_pp0p" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 12px">General and administrative</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,262,866</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,837,052</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 12px"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,753,161</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,926,270</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--SegmentOperatingLoss_zhWxhKc1W4Rh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">SEGMENT OPERATING LOSS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,725,330</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,905,381</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--NonoperatingIncomeExpenseAbstract_" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">OTHER INCOME (EXPENSES)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--InvestmentIncomeInterest_i_pp0p" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 12px">Interest income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">461,275</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187,848</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--CommitmentFee_iN_pp0d_di_zvsry3OFkgEj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 12px">Commitment fee</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,029</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--GainLossOnDispositionOfAssets1_i_pp0p" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 12px">Gain (loss) on disposal of property and equipment and intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(36,409</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28,800</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--OtherNonoperatingIncomeExpense_i_pp0p" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 12px">Other expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(76</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(262</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--NetIncomeLoss_i_pp0p" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">NET LOSS</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(6,300,540</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,697,024</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> Significant Segment Expenses The CODM regularly reviews the following significant expense categories in evaluating the segment performance: <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 20px; text-align: right">•</td> <td style="width: 7px"> </td> <td style="text-align: justify">Research and Development: includes costs related to personnel, laboratory and wafer fabrication materials and supplies, prototype device development and wafer fabrication expenses, and third-party consulting costs aimed at developing high-performance electro-optic polymer materials.</td></tr> <tr style="vertical-align: top"> <td style="text-align: right"> •</td> <td> </td> <td style="text-align: justify">General and Administrative: includes personnel costs, professional fees, and other overhead expenses.</td></tr> <tr style="vertical-align: top"> <td style="text-align: right"> •</td> <td> </td> <td style="text-align: justify">Cost of Sales: represents labor costs, material costs and manufacturing overhead costs associated with the production of materials transferred to the customer under the technology license and material supply agreement at the Company’s facility.</td></tr> </table> There were no other segment items for the three months ended March 31, 2026 and 2025. Segment assets The CODM does not regularly review asset information by segment; accordingly, the Company has not disclosed segment assets. Entity-Wide Disclosures <table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 20px; text-align: right">•</td> <td style="vertical-align: top; width: 7px"> </td> <td style="text-align: justify">Geographic Revenue Information: for the three months ended March 31, 2026, $29,167 of the Company’s net sales were generated outside the United States. For the three months ended March 31, 2025, $22,917 of the Company's net sales were generated outside the United States. Revenue is attributed to geographic areas based on the customer’s bill-to location. For the three months ended March 31, 2026 and 2025, <span id="xdx_90D_ecustom--SalesPercentage_c20260101__20260331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__srt--StatementGeographicalAxis__country--CH_zPumzHxGiDZf" title="Sales percentage"><span id="xdx_905_ecustom--SalesPercentage_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__srt--StatementGeographicalAxis__country--CH_zyl0lhfOVbq1" title="Sales percentage">100% of net sales were generated in Switzerland. </td></tr> <tr> <td style="vertical-align: top; text-align: right">•</td> <td style="vertical-align: top"> </td> <td style="text-align: justify">Long-lived assets: long-lived assets, consisting of property and equipment, intangible assets, and right of use assets under operating leases were all located in the United States and totaled $9,411,107 and $9,376,041 as of March 31, 2026 and December 31, 2025, respectively.</td></tr> <tr> <td style="vertical-align: top; width: 20px; text-align: right">•</td> <td style="vertical-align: top; width: 7px"> </td> <td style="text-align: justify">Major Customers: for three months ended March 31, 2026 and 2025, one customer accounted for <span id="xdx_900_ecustom--ConcentrationPercentage_c20260101__20260331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_pd" title="Concentration percentage"><span id="xdx_902_ecustom--ConcentrationPercentage_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_pd" title="Concentration percentage">10% or more of total revenue. The related revenue was attributable to the Company’s single reportable segment.</td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zcRJs45A3L9i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT REPORTING (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of reconciliation of segment operating loss </td><td> </td> <td colspan="2" id="xdx_494_20260101__20260331_zlz1A8IWeZik"> </td><td> </td><td> </td> <td colspan="2" id="xdx_490_20250101__20250331_zmBgmQBHeVp6"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended March 31, 2026</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three months ended March 31, 2025</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> </tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_401_eus-gaap--Revenues_i_pp0p" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left; padding-bottom: 1pt">NET SALES</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">29,167</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">22,917</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--CostOfGoodsAndServicesSold_i_pp0p" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>COST OF SALES</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,336</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,028</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingExpensesAbstract_iB_z4hTWDOF0WF" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">OPERATING EXPENSES</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--ResearchAndDevelopmentExpense_i_pp0p" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 12px">Research and development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,490,295</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,089,218</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--GeneralAndAdministrativeExpense_i_pp0p" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 12px">General and administrative</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,262,866</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,837,052</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 12px"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,753,161</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,926,270</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--SegmentOperatingLoss_zhWxhKc1W4Rh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">SEGMENT OPERATING LOSS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,725,330</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,905,381</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--NonoperatingIncomeExpenseAbstract_" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">OTHER INCOME (EXPENSES)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--InvestmentIncomeInterest_i_pp0p" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 12px">Interest income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">461,275</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187,848</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--CommitmentFee_iN_pp0d_di_zvsry3OFkgEj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 12px">Commitment fee</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,029</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--GainLossOnDispositionOfAssets1_i_pp0p" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 12px">Gain (loss) on disposal of property and equipment and intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(36,409</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28,800</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--OtherNonoperatingIncomeExpense_i_pp0p" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 12px">Other expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(76</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(262</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--NetIncomeLoss_i_pp0p" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">NET LOSS</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(6,300,540</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,697,024</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table>

29167

22917

1336

2028

3490295

3089218

3262866

1837052

6753161

4926270

-6725330 -4905381

461275

187848

8029

-36409

28800

-76

-262

-6300540

-4697024

29167

22917

1 1

9411107

9376041

0.10 0.10

NOTE 16 – SUBSEQUENT EVENTS On April 16, 2026, 402,500 underwriter warrants issued to an investment bank as a part of the December 17, 2025 offering were exercised for proceeds of $1,388,625. On April 20, 2026, the Company entered into an amendment to its sales agreement with Roth Capital Partners, LLC, as sales agent, to increase the amount of shares of common stock that may be sold under the Sales Agreement to $<span id="xdx_903_ecustom--AmountIncreasedForSaleOfCommonStock_pp0d_c20260401__20260420__us-gaap--TransactionTypeAxis__custom--SalesAgreementMember_zNdLObXWt3Fk" title="Amount increased for sale of common stock">51,404,500. As of the date of this filing, $<span id="xdx_90D_ecustom--AgreementToSellInvestCommonStockValueRemaingAmountAvailable_iI_pp0d_c20260515__srt--TitleOfIndividualAxis__custom--InvestmentBankingCompanyMember__us-gaap--TypeOfArrangementAxis__custom--SalesAgreementMember_zKTvUACXOkEk" title="Agreement to sell invest common stock value remaining amount available">3,385 remains available pursuant to the Roth Sales Agreement.

402500

1388625

51404500 3385 false false false false